[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 309
1. Shah VB, Amonkar GP, Deshpande JR, Bhalekar H: Mucinous adenocarcinoma of the renal pelvis with pseudomyxoma peritonei. Indian J Pathol Microbiol; 2008 Oct-Dec;51(4):536-7
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mucinous adenocarcinoma of the renal pelvis with pseudomyxoma peritonei.
  • Mucinous adenocarcinoma of the renal pelvis is an extremely rare tumor with very few case reports in literature.
  • Thus, a diagnosis of mucinous adenocarcinoma of the renal pelvis leading to pseudomyxoma peritonei was made.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Kidney Neoplasms / pathology. Kidney Pelvis / pathology. Neoplasms, Multiple Primary / pathology. Peritoneal Neoplasms / pathology. Pseudomyxoma Peritonei / pathology

  • Genetic Alliance. consumer health - Pseudomyxoma peritonei.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19008588.001).
  • [ISSN] 0377-4929
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


2. Shih CM, Huang CT, Chi CH, Lin JW, Pan CC: CA125-producing clear cell adenocarcinoma arising from the upper ureter and renal pelvis. J Chin Med Assoc; 2010 Jan;73(1):40-3
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CA125-producing clear cell adenocarcinoma arising from the upper ureter and renal pelvis.
  • Here, we present a case of clear cell adenocarcinoma arising from the upper ureter and renal pelvis of a postmenopausal woman with a ureteral stone.
  • Given the presence of intestinal and squamous metaplasia of the adjacent urothelium, we propose that this clear cell adenocarcinoma developed through a metaplastic process.
  • [MeSH-major] Adenocarcinoma, Clear Cell / pathology. CA-125 Antigen / blood. Kidney Neoplasms / pathology. Kidney Pelvis / pathology. Ureteral Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20103490.001).
  • [ISSN] 1728-7731
  • [Journal-full-title] Journal of the Chinese Medical Association : JCMA
  • [ISO-abbreviation] J Chin Med Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China (Republic : 1949- )
  • [Chemical-registry-number] 0 / CA-125 Antigen; 0 / CA-19-9 Antigen
  •  go-up   go-down


3. Yoshida T, Nishimura K, Harada Y, Ujike T, Uemura M, Nin M, Miyoshi S, Kawano K: [Primary adenocarcinoma of renal pelvis and ureter suspected as metastatic tumor: a case report]. Hinyokika Kiyo; 2007 Apr;53(4):247-50
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Primary adenocarcinoma of renal pelvis and ureter suspected as metastatic tumor: a case report].
  • A 58-year-old man, who had undergone sigmoidectomy for sigmoid colon adenocarcinoma 3 years earlier, was referred to our clinic because of left ureteral tumor incidentally found by computed tomography (CT).
  • Under the diagnosis of left ureteral carcinoma, retroperitoneoscopic left nephroureterectomy was performed.
  • Pathological examination revealed adenocarcinoma of the left renal pelvis and ureter.
  • Subtype of the adenocarcinoma was 'enteric type'.
  • By the transurethral resection of the tumors, bladder tumors appeared to be adenocarcinoma.
  • Carefully considering the pathological findings and clinical course, we concluded that the tumor was not metastatic but primary adenocarcinoma followed by intravesical recurrence.
  • [MeSH-major] Adenocarcinoma / secondary. Kidney Neoplasms / secondary. Kidney Pelvis. Neoplasms, Second Primary. Sigmoid Neoplasms / pathology. Ureteral Neoplasms / secondary. Urinary Bladder Neoplasms / diagnosis
  • [MeSH-minor] Colon, Sigmoid / surgery. Diagnosis, Differential. Humans. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17515075.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


Advertisement
4. Palacios A, Lima O, Massó P, Osório L, Versos R, Soares J, Marcelo F: [Tubulovillous adenocarcinoma of the renal pelvis. Case report]. Arch Esp Urol; 2006 Nov;59(9):916-9
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Tubulovillous adenocarcinoma of the renal pelvis. Case report].
  • [Transliterated title] Adenocarcinoma túbulovelloso de la pelvis renal. A propósito de un caso.
  • OBJECTIVE: To present a case of tubulovillous renal pelvis adenocarcinoma.
  • A nephrectomy was performed and pathological exam revealed tubulovillous renal pelvis adenocarcinoma.
  • CONCLUSIONS: Renal pelvis adenocarcinoma is a rare disease.
  • [MeSH-major] Adenocarcinoma / diagnosis. Kidney Neoplasms / diagnosis. Kidney Pelvis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17190219.001).
  • [ISSN] 0004-0614
  • [Journal-full-title] Archivos españoles de urología
  • [ISO-abbreviation] Arch. Esp. Urol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


5. Onishi T, Franco OE, Shibahara T, Arima K, Sugimura Y: Papillary adenocarcinoma of the renal pelvis and ureter producing carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 125. Int J Urol; 2005 Feb;12(2):214-6
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Papillary adenocarcinoma of the renal pelvis and ureter producing carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 125.
  • We report a case of advanced renal pelvis and ureter adenocarcinoma producing carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9) and carbohydrate antigen 125 (CA125).
  • Biopsy of the ureteral mass revealed papillary adenocarcinoma.
  • [MeSH-major] Adenocarcinoma, Papillary / immunology. Antigens, Neoplasm / metabolism. Kidney Neoplasms / immunology. Ureteral Neoplasms / immunology
  • [MeSH-minor] Aged. Female. Humans. Kidney Pelvis / pathology

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15733120.001).
  • [ISSN] 0919-8172
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Antigens, Neoplasm
  •  go-up   go-down


6. Shameem M, Akhtar J, Baneen U, Bhargava R, Ahmed Z, Sharma P, Khan NA, Hassan MJ: Primary peritoneal adenocarcinoma causes pleural effusion. N Am J Med Sci; 2010 Jun;2(6):281-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary peritoneal adenocarcinoma causes pleural effusion.
  • CONTEXT: The most common malignancies associated with malignant pleural effusions are carcinomas of the breast, lung, gastrointestinal tract, ovary and lymphomas.
  • Primary peritoneal adenocarcinoma is a very rare cause of malignant pleural effusion.
  • A cytologic examination of pleural fluid revealed adenocarcinoma cells.
  • A CECT of her abdomen and pelvis revealed heterogenous thickening of omentum with nodular appearances and small amount of ascites.
  • A histological examination of a peritoneal lesion was suggestive of adenocarcinoma.
  • CONCLUSIONS: The patient was diagnosed with a rare case of primary peritoneal adenocarcinoma with bilateral pleural effusion.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Obstet Gynecol. 1979 Nov;54(5):656-8 [503399.001]
  • [Cites] Int J Gynecol Pathol. 1994 Apr;13(2):120-6 [8005732.001]
  • [Cites] Gynecol Oncol. 1991 Jun;41(3):259-62 [1714418.001]
  • [Cites] Gynecol Oncol. 1991 Mar;40(3):230-6 [2013445.001]
  • [Cites] Obstet Gynecol. 1990 Jan;75(1):75-8 [2296426.001]
  • [Cites] Gynecol Oncol. 1988 Oct;31(2):315-20 [2458994.001]
  • [Cites] Cancer. 1989 Jul 1;64(1):110-5 [2731107.001]
  • [Cites] J Surg Oncol. 1998 Jul;68(3):173-8 [9701210.001]
  • [Cites] Gynecol Oncol. 1998 Nov;71(2):230-9 [9826465.001]
  • [Cites] Am J Obstet Gynecol. 1959 Jan;77(1):197-200 [13606191.001]
  • [Cites] Eur J Gynaecol Oncol. 1988;9(6):474-8 [3234425.001]
  • [Cites] Arch Pathol Lab Med. 1995 Nov;119(11):1044-9 [7487405.001]
  • [Cites] Gynecol Oncol. 1993 Nov;51(2):171-4 [8276289.001]
  • [Cites] Gynecol Oncol. 1993 Sep;50(3):347-51 [8406199.001]
  • [Cites] Int J Gynecol Pathol. 1995 Oct;14(4):310-8 [8598333.001]
  • [Cites] Gynecol Oncol. 1997 Jul;66(1):160-3 [9234939.001]
  • [Cites] Gynecol Oncol. 1997 Nov;67(2):141-6 [9367697.001]
  • [Cites] Histopathology. 2005 Sep;47(3):231-47 [16115224.001]
  • [Cites] Eur J Gynaecol Oncol. 2006;27(2):197-9 [16620072.001]
  • [Cites] Gynecol Oncol. 2007 Jun;105(3):762-8 [17383715.001]
  • [Cites] Ann Oncol. 2001 Apr;12(4):563-7 [11398893.001]
  • [Cites] Int J Gynecol Cancer. 2003 Nov-Dec;13(6):764-70 [14675312.001]
  • [Cites] Obstet Gynecol. 1989 May;73(5 Pt 1):786-92 [2704507.001]
  • [Cites] Hum Pathol. 1989 May;20(5):426-36 [2707793.001]
  • [Cites] Histopathology. 1988 May;12(5):527-32 [3397046.001]
  • [Cites] Int J Gynecol Pathol. 1985;4(1):11-23 [3880151.001]
  • [Cites] Cancer. 1985 Aug 15;56(4):905-9 [4016683.001]
  • [Cites] Lancet. 1982 Oct 9;2(8302):795-7 [6126666.001]
  • [Cites] Hum Pathol. 1990 Jan;21(1):99-110 [1688545.001]
  • (PMID = 22574304.001).
  • [ISSN] 1947-2714
  • [Journal-full-title] North American journal of medical sciences
  • [ISO-abbreviation] N Am J Med Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3347636
  • [Keywords] NOTNLM ; Malignant pleural effusion / primary peritoneal adenocarcinoma
  •  go-up   go-down


7. Kobori Y, Shigehara K, Amano T, Takemae K: [Port site metastasis of primary adenocarcinoma of the renal pelvis after a laparoscopic nephrectomy: a case report]. Hinyokika Kiyo; 2005 Feb;51(2):105-8
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Port site metastasis of primary adenocarcinoma of the renal pelvis after a laparoscopic nephrectomy: a case report].
  • We report a case of port site metastasis of primary adenocarcinoma of the renal pelvis after a laparoscopic nephrectomy.
  • However, antegrade and retrograde pyelography revealed no filling defects and urine cytopathology for renal pelvis showed no malignancy.
  • There were some papillary tumors in the renal pelvis and a histopathological examination of the tumor revealed a papillary adenocarcinoma.
  • However, 3 months later, the patient developed metastasis at the trocar site and the serum level of CA19-9 elevated to 6,720 U/ml.
  • She died of multiple metastases from adenocarcinoma of the renal pelvis 4 months after port site metastasis.
  • [MeSH-major] Adenocarcinoma, Papillary / pathology. Adenocarcinoma, Papillary / secondary. Kidney Neoplasms / pathology. Kidney Neoplasms / surgery. Kidney Pelvis. Laparoscopy. Muscle Neoplasms / secondary. Nephrectomy. Psoas Muscles

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15773363.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CA-19-9 Antigen
  •  go-up   go-down


8. Xambre L, Cerqueira M, Cardoso A, Correia T, Macedo Dias A, Carreira F, Galán T: [Primary mucinous adenocarcinoma of the renal pelvis--adicional case report]. Actas Urol Esp; 2009 Feb;33(2):200-4
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Primary mucinous adenocarcinoma of the renal pelvis--adicional case report].
  • [Transliterated title] Adenocarcinoma mucinoso primário de pélvis renal--caso adicional.
  • Mucinous adenocarcinoma of the renal pelvis may be classified as among the rarest neoplasms of the genitourinary tract.
  • The authors report an adicional clinical case with particular aspects in what concerns differential diagnosis.
  • [MeSH-major] Adenocarcinoma, Mucinous. Kidney Neoplasms. Kidney Pelvis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19418847.001).
  • [ISSN] 0210-4806
  • [Journal-full-title] Actas urologicas españolas
  • [ISO-abbreviation] Actas Urol Esp
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 13
  •  go-up   go-down


9. Gómez García I, Rodríguez Patrón R, Conde Someso S, Sanz Mayayo E, García Navas R, Palmeiro A: [Renal synchronous tumor: association of renal adenocarcinoma and transitional tumor of renal pelvis, in the same kidney, an exceptional discovery]. Actas Urol Esp; 2005 Jul-Aug;29(7):711-4
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Renal synchronous tumor: association of renal adenocarcinoma and transitional tumor of renal pelvis, in the same kidney, an exceptional discovery].
  • [Transliterated title] Tumor sincrónico renal: asociación de adenocarcinoma renal y tumor transicional de pelvis renal, en el mismo riñón, un hallazgo excepcional.
  • The simultaneous appearance of a carcinoma of renal cells, and a transitional tumour of pelvis in the same kidney, they suppose an exceptional fact not existing but of 30 cases published in the world, presenting an approximate incidence of 0.14% of the pathology renal tumoral.
  • [MeSH-minor] Aged. Humans. Kidney Pelvis / pathology. Kidney Pelvis / radiography. Kidney Pelvis / surgery. Male. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16180325.001).
  • [ISSN] 0210-4806
  • [Journal-full-title] Actas urologicas españolas
  • [ISO-abbreviation] Actas Urol Esp
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


10. Torres Gómez FJ, Torres Olivera FJ: [Renal pelvis mucinous carcinoma. Case report]. Arch Esp Urol; 2006 Apr;59(3):300-2
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Renal pelvis mucinous carcinoma. Case report].
  • [Transliterated title] Carcinoma mucinoso de pelvis renal. A propósito de un caso.
  • METHODS: We report the case of a 50-year-old male with history of recurrent lithiasis whose radological tests discovered a heterogeneous renal pelvis lesion.
  • RESULTS: The histologic study of the lesions determined the diagnosis of transitional cell carcinoma of the renal pelvis with ample mucinous differentiation.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Carcinoma, Transitional Cell / pathology. Kidney Neoplasms / pathology. Kidney Pelvis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16724719.001).
  • [ISSN] 0004-0614
  • [Journal-full-title] Archivos españoles de urología
  • [ISO-abbreviation] Arch. Esp. Urol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


11. Das A, Thomas S, Zablotska LB, Neugut AI, Chak A: Association of esophageal adenocarcinoma with other subsequent primary cancers. J Clin Gastroenterol; 2006 May-Jun;40(5):405-11
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Association of esophageal adenocarcinoma with other subsequent primary cancers.
  • PURPOSE: Esophageal adenocarcinoma shares risk factors such as obesity and smoking with other common cancers.
  • The association of esophageal adenocarcinoma with other primary cancers has not been systematically evaluated.
  • The authors used the Surveillance, Epidemiology and End-Results database of the National Cancer Institute to explore the association of esophageal adenocarcinoma with other primary cancers.
  • PATIENTS AND METHODS: All adult patients with esophageal cancers, both adenocarcinoma and squamous cell carcinoma diagnosed between 1973 and 2001, were identified from the Surveillance, Epidemiology, and End-Results database, and standardized incidence rates were calculated for all subsequent primary cancers in these patients.
  • RESULTS: In comparison with a standard population, patients with esophageal adenocarcinoma were at higher risk for the development of another subsequent cancer, specifically, cancers of the oral cavity and pharynx, lung and bronchus, and kidney and renal pelvis, and adenocarcinoma of the colon/rectum and pancreas.
  • There was either no association or even a negative association of esophageal adenocarcinoma with other obesity-related cancers such as breast, uterine, and prostate cancers.
  • CONCLUSIONS: Patients with esophageal adenocarcinoma and squamous cell carcinoma are at increased risk for the development of specific second primary cancers that share smoking as a common risk factor.
  • Esophageal adenocarcinoma does not have a strong association with obesity-related cancers with respect to the relative risk for the development of subsequent primary cancers.
  • [MeSH-major] Adenocarcinoma / pathology. Carcinoma, Squamous Cell / pathology. Esophageal Neoplasms / pathology. Neoplasms, Second Primary / pathology. Smoking / adverse effects

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Smoking.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16721221.001).
  • [ISSN] 0192-0790
  • [Journal-full-title] Journal of clinical gastroenterology
  • [ISO-abbreviation] J. Clin. Gastroenterol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA89155; United States / NIDDK NIH HHS / DK / K24 DK028000
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  •  go-up   go-down


12. Monge AH, Pineda RP, del Rocio Estrada Hernandez M, Juárez EG, García JC: [Fallopian tube primary invasive adenocarcinoma associated with acute inflammatory pelvic disease. Case report and literature review]. Ginecol Obstet Mex; 2008 Feb;76(2):118-24
Hazardous Substances Data Bank. CLINDAMYCIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Fallopian tube primary invasive adenocarcinoma associated with acute inflammatory pelvic disease. Case report and literature review].
  • [Transliterated title] Adenocarcinoma invasor primario de trompa de falopio concomitante con enfermedad pélvica inflamatoria aguda. Comunicación de un caso y revisión de la bibliografía.
  • The primary fallopian tube invader adenocarcinoma is a preoperative diagnosis rarely reported in the literature, because is the most uncommon of all gynecological tumors, with prevalence from 0.3 to 1.8%.
  • The most frequent signs and symptoms are abdominal pain or a pelvic mass in 80% of cases; transvaginal bleeding in 50%, intense transvaginal serohematic discharge (hidrops tubae profluens) in 11.1%, and peritonitis in pelvis in 3.7%.
  • In 25 to 60% of the cases a report of adenocarcinoma in the pap smear with negative endometrial biopsy can be found.
  • [MeSH-major] Adenocarcinoma / genetics. Fallopian Tube Neoplasms / complications. Pelvic Inflammatory Disease / complications

  • MedlinePlus Health Information. consumer health - Pelvic Inflammatory Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18798405.001).
  • [ISSN] 0300-9041
  • [Journal-full-title] Ginecología y obstetricia de México
  • [ISO-abbreviation] Ginecol Obstet Mex
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Mexico
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 3U02EL437C / Clindamycin; 75J73V1629 / Ceftriaxone
  • [Number-of-references] 10
  •  go-up   go-down


13. Ho CH, Lin WC, Pu YS, Yu HJ, Huang CY: Primary mucinous adenocarcinoma of renal pelvis with carcinoembryonic antigen production. Urology; 2008 May;71(5):984.e7-8
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary mucinous adenocarcinoma of renal pelvis with carcinoembryonic antigen production.
  • We report a case of primary mucinous adenocarcinoma of the renal pelvis associated with carcinoembryonic antigen (CEA) production.
  • Radical nephrectomy was performed, and the histopathologic examination revealed a mucinous adenocarcinoma that was strongly positive for CEA.
  • [MeSH-major] Adenocarcinoma, Mucinous / metabolism. Carcinoembryonic Antigen / biosynthesis. Kidney Neoplasms / metabolism. Kidney Pelvis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Urology. 2009 Aug;74(2):475 [19646634.001]
  • (PMID = 18291507.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Carcinoembryonic Antigen
  •  go-up   go-down


14. Bal A, Aulakh R, Mohan H, Bawa AS: Mucinous adenocarcinoma of the renal pelvis presenting as pyonephrosis: a case report. Indian J Pathol Microbiol; 2007 Apr;50(2):336-7
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mucinous adenocarcinoma of the renal pelvis presenting as pyonephrosis: a case report.
  • Tumours of the renal pelvis are rare.
  • We present a case of primary mucinous adenocarcinoma of the renal pelvis masquerading as pyonephrosis clinically and diagnosed on histopathologic examination.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Kidney Neoplasms / pathology
  • [MeSH-minor] Diagnosis, Differential. Humans. Kidney Pelvis. Male. Middle Aged. Pyonephrosis / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17883063.001).
  • [ISSN] 0377-4929
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


15. Shimada M, Kigawa J, Nishimura R, Hiura M, Hatae M, Takehara K, Sato A, Kurachi H, Mizunuma H, Sugiyama T: Comparison of the outcome between cervical adenocarcinoma and squamous cell carcinoma patients with adjuvant radiotherapy after radical surgery: SGSG/TGCU Intergroup Surveillance. J Clin Oncol; 2009 May 20;27(15_suppl):5585

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison of the outcome between cervical adenocarcinoma and squamous cell carcinoma patients with adjuvant radiotherapy after radical surgery: SGSG/TGCU Intergroup Surveillance.
  • : 5585 Background: We conducted the present surveillance to clarify the significance of adjuvant radiotherapy and the cause of poor outcome of adenocarcinoma (AC).
  • The local failure defined as recurrence in stump and pelvis was more frequent in patients with AC compared with SCC (24.6% vs.10.7%).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962392.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


16. Renaud F, Berthon N, Lemaitre L, Castillo C, Copin MC, Aubert S, Leroy X: [Primary intestinal-type adenocarcinoma of the renal pelvis associated with lithiasis: a case report]. Ann Pathol; 2010 Oct;30(5):386-9
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Primary intestinal-type adenocarcinoma of the renal pelvis associated with lithiasis: a case report].
  • [Transliterated title] Adénocarcinome de type intestinal primitif du bassinet: à propos d'un cas développé au contact d'une lithiase coralliforme.
  • A case of primary adenocarcinoma of the renal pelvis occurring in a 57-year-old woman who had no previous history is reported.
  • Diagnosis of intestinal-type adenocarcinoma of the renal pelvis was established on histological examination.
  • Primary adenocarcinoma of renal pelvis is a rare and often mucinous intestinal-type tumour.
  • The main differential diagnosis to eliminate is secondary lesions to the kidney of adenocarcinoma from another origin.
  • [MeSH-major] Adenocarcinoma / complications. Kidney Calculi / complications. Kidney Neoplasms / complications. Kidney Pelvis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Masson SAS. All rights reserved.
  • (PMID = 21055527.001).
  • [ISSN] 0242-6498
  • [Journal-full-title] Annales de pathologie
  • [ISO-abbreviation] Ann Pathol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


17. Miller B, Dunn J, Dalrymple J, Krivak TC: Pelvic sidewall adenocarcinoma after definitive therapy for cervical adenocarcinoma in situ. Gynecol Oncol; 2005 Nov;99(2):489-92
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pelvic sidewall adenocarcinoma after definitive therapy for cervical adenocarcinoma in situ.
  • BACKGROUND: Traditionally, hysterectomy is considered definitive therapy for cervical adenocarcinoma in situ (AIS) in women beyond childbearing.
  • CASE: A 45-year-old gravida 2, para 2 patient presented with cervical dysplasia and on pathology review of the large loop excision procedure cervical adenocarcinoma in situ was diagnosed.
  • Final pathology revealed adenocarcinoma in situ with negative margins.
  • A computed tomography (CT) scan of the abdomen and pelvis showed a pelvic sidewall mass.
  • A CT-guided biopsy of the mass was consistent with invasive adenocarcinoma of the endocervical type.
  • Despite undergoing definitive surgery, a residual focus of disease may remain leading to invasive adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / pathology. Adenocarcinoma / surgery. Carcinoma in Situ / surgery. Pelvic Neoplasms / pathology. Uterine Cervical Neoplasms / surgery
  • [MeSH-minor] Female. Humans. Hysterectomy. Middle Aged. Neoplasm Recurrence, Local / drug therapy. Neoplasm Recurrence, Local / pathology. Neoplasm Recurrence, Local / radiotherapy

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16054200.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


18. Holst LM, Jensen JB, Bue P, Hansen LG: [Primary adenocarcinoma of the ureter]. Ugeskr Laeger; 2009 Feb 9;171(7):534

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Primary adenocarcinoma of the ureter].
  • Primary adenocarcinomas of the renal pelvis and ureter are very rare tumours, representing less than 1% of the malignant tumours of the ureter and the renal pelvis.
  • A case of adenocarcinoma of the ureter in a 62-year-old woman with no prior history of urological disease is presented.
  • [MeSH-major] Adenocarcinoma / diagnosis. Ureteral Neoplasms / diagnosis
  • [MeSH-minor] Fatal Outcome. Female. Humans. Middle Aged. Neoplasm Recurrence, Local

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19210942.001).
  • [ISSN] 1603-6824
  • [Journal-full-title] Ugeskrift for laeger
  • [ISO-abbreviation] Ugeskr. Laeg.
  • [Language] dan
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


19. Jackson AS, Sohaib SA, Staffurth JN, Huddart RA, Parker CC, Horwich A, Dearnaley DP: Distribution of lymph nodes in men with prostatic adenocarcinoma and lymphadenopathy at presentation: a retrospective radiological review and implications for prostate and pelvis radiotherapy. Clin Oncol (R Coll Radiol); 2006 Mar;18(2):109-16
MedlinePlus Health Information. consumer health - Prostate Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Distribution of lymph nodes in men with prostatic adenocarcinoma and lymphadenopathy at presentation: a retrospective radiological review and implications for prostate and pelvis radiotherapy.
  • AIMS: To describe the distribution of enlarged lymph nodes by nodal group found radiologically in patients presenting with adenocarcinoma of the prostate.
  • [MeSH-major] Adenocarcinoma / pathology. Lymphatic Irradiation. Lymphatic Metastasis / pathology. Prostatic Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Pelvis. Retrospective Studies. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16523810.001).
  • [ISSN] 0936-6555
  • [Journal-full-title] Clinical oncology (Royal College of Radiologists (Great Britain))
  • [ISO-abbreviation] Clin Oncol (R Coll Radiol)
  • [Language] eng
  • [Grant] United Kingdom / Medical Research Council / / G0501019
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


20. Jolly S, Vargas C, Kumar T, Weiner S, Brabbins D, Chen P, Floyd W, Martinez AA: Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer. Gynecol Oncol; 2005 Jun;97(3):887-92
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer.
  • OBJECTIVE: Postoperative management of early stage adenocarcinoma of the endometrium remains controversial.
  • We reviewed and compared our results treating early stage endometrial adenocarcinoma using hypofractionated high dose rate (HDR) vaginal brachytherapy (VB) alone with the results of the GOG-99.
  • Of these, 50 FIGO stage I-II (occult) adenocarcinoma (no clear cell or serous papillary) of the endometrium were managed with HDR hypofractionated VB as monotherapy using Iridium-192 to a dose of 30 Gy in 6 fractions twice weekly prescribed to a depth of 5 mm and median length of 4 cm.
  • In our study, one patient failed in the vagina alone and a second patient failed in the vagina and pelvis.
  • In the GOG-99, the vagina as a component of locoregional failure was also the most common failure site in the no RT arm 77.8% (n = 14) and in the RT arm 100% (n = 3).
  • CONCLUSION: Stage I-II (occult) endometrial adenocarcinoma treated with postoperative HDR vaginal brachytherapy has similar overall survival, locoregional failure rates, and cumulative recurrence rates to standard fractionation external beam pelvic RT with the benefit of much lower toxicity rates and shorter overall treatment time.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Brachytherapy / methods. Endometrial Neoplasms / radiotherapy
  • [MeSH-minor] Aged. Dose Fractionation. Female. Humans. Middle Aged. Neoplasm Staging. Radiotherapy, Adjuvant

  • Genetic Alliance. consumer health - Vaginal cancer.
  • Genetic Alliance. consumer health - Endometrial cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15943991.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


21. Hauth E, Libera H, Kimmig R, Forsting M: [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy]. Rofo; 2006 Mar;178(3):316-23
Hazardous Substances Data Bank. TAMOXIFEN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
  • PURPOSE: The purpose of the study was to determine the value of MR imaging of the pelvis in the diagnostic work-up of the endometrium in breast cancer patients in tamoxifen therapy.
  • MATERIALS AND METHODS: MR imaging of the pelvis was performed on 24 patients (mean: 62 years, range: 51 - 74 years) and 30 healthy women (mean: 65 years, range: 51 - 73 years).
  • CONCLUSION: MR imaging might be helpful in the diagnosis of endometrium pathologies during tamoxifen therapy.
  • Therefore, MR imaging of the pelvis could be used as a diagnostic tool in the follow-up diagnosis of the endometrium in breast cancer patients in tamoxifen therapy.
  • [MeSH-major] Adenocarcinoma / diagnosis. Antineoplastic Agents, Hormonal / adverse effects. Breast Neoplasms / drug therapy. Cervix Uteri / drug effects. Endometrial Neoplasms / diagnosis. Endometrium / drug effects. Endometrium / pathology. Magnetic Resonance Imaging / methods. Polyps / diagnosis. Tamoxifen / adverse effects. Tamoxifen / therapeutic use. Uterus / drug effects
  • [MeSH-minor] Aged. Confidence Intervals. Data Interpretation, Statistical. Endometrial Hyperplasia / chemically induced. Endometrial Hyperplasia / diagnosis. Endometrial Hyperplasia / pathology. Female. Humans. Hysterectomy. Middle Aged. Neoplasm Staging. Radiology Information Systems. Time Factors


22. Khademi S, Westphalen AC, Webb EM, Joe BN, Badiee S, Hawkins RA, Coakley FV: Frequency and etiology of solitary hot spots in the pelvis at whole-body positron emission tomography/computed tomography imaging. Clin Imaging; 2009 Jan-Feb;33(1):44-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Frequency and etiology of solitary hot spots in the pelvis at whole-body positron emission tomography/computed tomography imaging.
  • PURPOSE: To determine the frequency and etiology of a single hypermetabolic focus within the pelvis with no other areas of increased 18-fluorodeoxyglucose (FDG) uptake in the reminder of the whole body in an oncological population.
  • METHOD AND MATERIALS: We retrospectively examined the first 700 whole-body PET/CT scans performed at our institution for baseline staging or follow-up of cancer and identified all patients with a solitary focus of increased FDG uptake in the pelvis.
  • RESULTS: Eight (1.1%) of the 700 patients had a solitary hot spot in the pelvis at positron emission tomography (PET)/computed tomography (CT) imaging, consisting of seven of 380 women and one of 320 men.
  • In the man, uptake was due to recurrent rectosigmoid adenocarcinoma.
  • None of the 700 patients was found to have metastatic disease in the pelvis.

  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Nucl Med. 2002 Oct;43(10):1339-42 [12368372.001]
  • [Cites] J Nucl Med. 2004 Feb;45(2):266-71 [14960646.001]
  • [Cites] J Comput Assist Tomogr. 2004 May-Jun;28(3):340-2 [15100537.001]
  • [Cites] AJR Am J Roentgenol. 2004 Oct;183(4):1143-7 [15385321.001]
  • [Cites] J Nucl Med. 1999 Apr;40(4):591-603 [10210218.001]
  • [Cites] J Nucl Med. 1999 Oct;40(10):1706-15 [10520713.001]
  • [Cites] J Nucl Med. 2007 Jan;48 Suppl 1:78S-88S [17204723.001]
  • [Cites] Nucl Med Commun. 2005 Aug;26(8):671-87 [16000985.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):757-63 [15772859.001]
  • [Cites] AJR Am J Roentgenol. 2006 Feb;186(2):308-19 [16423932.001]
  • [Cites] Obstet Gynecol Clin North Am. 2006 Mar;33(1):85-95 [16504808.001]
  • [Cites] Clin Nucl Med. 2006 Dec;31(12):781-7 [17117072.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2005 May;32(5):549-56 [15599527.001]
  • (PMID = 19135929.001).
  • [ISSN] 1873-4499
  • [Journal-full-title] Clinical imaging
  • [ISO-abbreviation] Clin Imaging
  • [Language] ENG
  • [Grant] United States / NIBIB NIH HHS / EB / 1 T32 EB001631-01; United States / NIBIB NIH HHS / EB / EB001631-01A1; United States / NIBIB NIH HHS / EB / T32 EB001631-01A1; United States / NIBIB NIH HHS / EB / T32 EB001631-02; United States / NIBIB NIH HHS / EB / T32 EB001631
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  • [Other-IDs] NLM/ NIHMS125433; NLM/ PMC2743966
  •  go-up   go-down


23. Gulwani H, Jain A: Primary papillary mucinous adenocarcinoma of the ureter mimicking genitourinary tuberculosis. Patholog Res Int; 2010;2010:738407

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary papillary mucinous adenocarcinoma of the ureter mimicking genitourinary tuberculosis.
  • Primary adenocarcinomas of the renal pelvis and ureter are rare and account for less than 1% of all malignancies at this site.
  • We report a case of primary papillary mucinous adenocarcinoma of the ureter that clinically mimicked genitourinary tuberculosis.
  • Early diagnosis is important for the better outcome.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21151719.001).
  • [ISSN] 2042-003X
  • [Journal-full-title] Pathology research international
  • [ISO-abbreviation] Patholog Res Int
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2990121
  •  go-up   go-down


24. Chalasani V, Macek P, O'Neill GF, Barret W: Ureteric stricture secondary to unusual extension of prostatic adenocarcinoma. Can J Urol; 2010 Feb;17(1):5031-4
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ureteric stricture secondary to unusual extension of prostatic adenocarcinoma.
  • This article describes an unusual finding in a patient who presented with an adenocarcinoma of the prostate and right hydronephrosis.
  • Cystoscopy showed an exophytic superficial transitional cell carcinoma (TCC) of the bladder and a transrectal biopsy of the prostate confirmed adenocarcinoma Gleason score 4+3.
  • Staging investigations (CT pelvis and bone scan) were negative; androgen deprivation therapy was therefore initiated for the prostatic adenocarcinoma.
  • With a working diagnosis of upper tract TCC, right open nephroureterectomy was performed.
  • Final histology showed prostatic adenocarcinoma infiltrating the adventitia of the entire ureter up to the level of the renal pelvis.
  • A rare cause of ureteric stricture, contiguous spread of prostatic adenocarcinoma, should be considered in the differential diagnosis of patients presenting with upper tract obstruction and a known history of prostatic adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / pathology. Prostatic Neoplasms / pathology. Ureter / pathology. Ureteral Obstruction / etiology
  • [MeSH-minor] Aged. Humans. Male. Neoplasm Invasiveness

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20156388.001).
  • [ISSN] 1195-9479
  • [Journal-full-title] The Canadian journal of urology
  • [ISO-abbreviation] Can J Urol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Canada
  •  go-up   go-down


25. Gilligan T, Dreicer R: The atypical urothelial cancer patient: management of bladder cancers of non-transitional cell histology and cancers of the ureters and renal pelvis. Semin Oncol; 2007 Apr;34(2):145-53
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The atypical urothelial cancer patient: management of bladder cancers of non-transitional cell histology and cancers of the ureters and renal pelvis.
  • Non-transitional cell neoplasms of the bladder and upper tract transitional cell carcinomas (ureter and renal pelvis) represent only a small fraction of urothelial carcinomas.
  • [MeSH-minor] Adenocarcinoma / therapy. Carcinoma, Small Cell / therapy. Carcinoma, Squamous Cell / therapy. Humans. Kidney Pelvis. Schistosomiasis haematobia / complications. Urachus

  • Genetic Alliance. consumer health - Kidney cancer.
  • Genetic Alliance. consumer health - Bladder cancer.
  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17382798.001).
  • [ISSN] 0093-7754
  • [Journal-full-title] Seminars in oncology
  • [ISO-abbreviation] Semin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 94
  •  go-up   go-down


26. Poynor EA, Marshall D, Sonoda Y, Slomovitz BM, Barakat RR, Soslow RA: Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization. Gynecol Oncol; 2006 Dec;103(3):960-5
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
  • OBJECTIVE: To evaluate the clinicopathologic features of microinvasive adenocarcinoma of the cervix in order to guide the management of patients with this disease.
  • MATERIALS AND METHODS: A retrospective review was conducted of patients diagnosed with early invasive, <or=5 mm stromal invasion, adenocarcinoma of the cervix by a cervical conization between 1992 and 1999 at our institution.
  • Ten patients had positive conization margins for invasive cancer, 3 patients had margins positive for adenocarcinoma in situ, 14 patients had negative margins, and in 6 patients the margin status could not be evaluated.
  • CONCLUSIONS: Historically, the standard management of early invasive adenocarcinoma of the cervix has been controversial, and some clinicians continue to favor radical treatments.
  • [MeSH-major] Adenocarcinoma / epidemiology. Adenocarcinoma / surgery. Conization / utilization. Outcome Assessment (Health Care). Uterine Cervical Neoplasms / epidemiology. Uterine Cervical Neoplasms / surgery
  • [MeSH-minor] Adult. Female. Humans. Lymphatic Metastasis. Medical Records. Middle Aged. Neoplasm Invasiveness. New York City / epidemiology. Pelvis. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16860853.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


27. Ring KL, Young JL, Dunlap NE, Andersen WA, Schneider BF: Extended-field radiation therapy with whole pelvis radiotherapy and cisplatin chemosensitization in the treatment of IB2-IIIB cervical carcinoma: a retrospective review. Am J Obstet Gynecol; 2009 Jul;201(1):109.e1-6
Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extended-field radiation therapy with whole pelvis radiotherapy and cisplatin chemosensitization in the treatment of IB2-IIIB cervical carcinoma: a retrospective review.
  • OBJECTIVE: This retrospective study evaluated the toxicity of extended-field radiation therapy (EFRT), whole pelvis radiotherapy, and concurrent chemotherapy in patients treated with IB2-IIIB cervical carcinoma.
  • STUDY DESIGN: Patients treated with EFRT, whole pelvis radiotherapy, and concurrent chemotherapy were analyzed for toxicity.
  • Median prescribed dose to the whole pelvis was 45 Gy (45-50 Gy).
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / radiotherapy. Adult. Carcinoma, Adenosquamous / pathology. Carcinoma, Adenosquamous / radiotherapy. Combined Modality Therapy. Disease Progression. Female. Humans. Kaplan-Meier Estimate. Lymphatic Metastasis. Middle Aged. Neoplasm Staging. Radiotherapy Dosage. Radiotherapy Planning, Computer-Assisted. Retrospective Studies. Young Adult

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19398095.001).
  • [ISSN] 1097-6868
  • [Journal-full-title] American journal of obstetrics and gynecology
  • [ISO-abbreviation] Am. J. Obstet. Gynecol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiation-Sensitizing Agents; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


28. Wu G, Bybel B, Brunken R, Lin H, Neumann D: PET detection of solitary distant skeletal muscle metastasis of esophageal adenocarcinoma. Clin Nucl Med; 2005 May;30(5):335-7
MedlinePlus Health Information. consumer health - Esophageal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] PET detection of solitary distant skeletal muscle metastasis of esophageal adenocarcinoma.
  • A 67-year-old man with progressive dysphagia was recently diagnosed with a gastroesophageal junction adenocarcinoma.
  • Contrast-enhanced CT scans of the abdomen and pelvis reported a large GE junction tumor without evidence of metastatic disease.
  • FDG positron emission tomography revealed intense tracer accumulation in the soft tissue mass at the GE junction consistent with the primary neoplasm.
  • Needle biopsy was performed and confirmed metastatic esophageal adenocarcinoma.
  • A case of skeletal muscle metastases from late-stage (IV) gastroesophageal adenocarcinoma was previously reported.
  • [MeSH-major] Adenocarcinoma / radionuclide imaging. Adenocarcinoma / secondary. Esophageal Neoplasms / radionuclide imaging. Fluorodeoxyglucose F18. Muscle Neoplasms / radionuclide imaging. Muscle Neoplasms / secondary. Positron-Emission Tomography / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15827406.001).
  • [ISSN] 0363-9762
  • [Journal-full-title] Clinical nuclear medicine
  • [ISO-abbreviation] Clin Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


29. Takemoto S, Ushijima K, Nakaso K, Fujiyoshi N, Kamura T: Primary adenocarcinoma of the vagina successfully treated with neoadjuvant chemotherapy consisting of paclitaxel and carboplatin. J Obstet Gynaecol Res; 2009 Jun;35(3):579-83
Hazardous Substances Data Bank. CARBOPLATIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary adenocarcinoma of the vagina successfully treated with neoadjuvant chemotherapy consisting of paclitaxel and carboplatin.
  • Primary vaginal adenocarcinoma unassociated with antenatal diethylstilbestrol (DES) exposure is extremely rare.
  • She had a solid tumor in the recto-vaginal space, diagnosed as FIGO stage III vaginal adenocarcinoma.
  • Thereafter, radiotherapy was applied to the pelvis and vagina in order to reinforce the state of remission.
  • [MeSH-major] Adenocarcinoma / drug therapy. Carboplatin / administration & dosage. Neoadjuvant Therapy. Paclitaxel / administration & dosage. Vaginal Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Vaginal Cancer.
  • Hazardous Substances Data Bank. TAXOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19527405.001).
  • [ISSN] 1341-8076
  • [Journal-full-title] The journal of obstetrics and gynaecology research
  • [ISO-abbreviation] J. Obstet. Gynaecol. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] BG3F62OND5 / Carboplatin; P88XT4IS4D / Paclitaxel
  •  go-up   go-down


30. Quadros CA, Lopes A, Araújo I: Retroperitoneal and lateral pelvic lymphadenectomy mapped by lymphoscintigraphy for rectal adenocarcinoma staging. Jpn J Clin Oncol; 2010 Aug;40(8):746-53

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Retroperitoneal and lateral pelvic lymphadenectomy mapped by lymphoscintigraphy for rectal adenocarcinoma staging.
  • BACKGROUND: The good prognosis of retroperitoneal and lateral pelvic lymphadenectomy has raised the question of whether total mesorectal excision is suitable for adequate staging of rectal adenocarcinoma patients.
  • The aims of this study were to determine the accuracy of dye and probe detection of metastatic retroperitoneal and/or lateral pelvic nodes and to define the upstaging impact of retroperitoneal and lateral pelvic lymphadenectomy in rectal adenocarcinoma patients.
  • METHODS: Ninety-seven rectal adenocarcinoma patients were submitted to total mesorectal excision and retroperitoneal and lateral pelvic lymphadenectomy.
  • [MeSH-major] Adenocarcinoma / radionuclide imaging. Adenocarcinoma / secondary. Lymph Nodes / radionuclide imaging. Monitoring, Intraoperative / methods. Neoplasm Staging / methods. Rectal Neoplasms / radionuclide imaging. Rectal Neoplasms / surgery
  • [MeSH-minor] Biopsy. Female. Humans. Lymph Node Excision / methods. Lymphatic Metastasis. Male. Middle Aged. Organotechnetium Compounds. Pelvis. Phytic Acid. Radiopharmaceuticals. Retroperitoneal Space

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20457722.001).
  • [ISSN] 1465-3621
  • [Journal-full-title] Japanese journal of clinical oncology
  • [ISO-abbreviation] Jpn. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Organotechnetium Compounds; 0 / Radiopharmaceuticals; 0 / technetium phytate; 7IGF0S7R8I / Phytic Acid
  •  go-up   go-down


31. Geisler JP, Linnemeier GC, Manahan KJ: Pelvic and para-aortic lymphadenectomy in patients with endometrioid adenocarcinoma of the endometrium. Int J Gynaecol Obstet; 2007 Jul;98(1):39-43

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pelvic and para-aortic lymphadenectomy in patients with endometrioid adenocarcinoma of the endometrium.
  • BACKGROUND: The purpose is to determine the rate of lymph node metastases in women with endometrioid adenocarcinoma of the endometrium (EAE) undergoing systematic lymphadenectomy.
  • [MeSH-major] Adenocarcinoma / pathology. Endometrial Neoplasms / pathology. Lymph Node Excision. Lymphatic Metastasis / pathology
  • [MeSH-minor] Female. Humans. Incidence. Para-Aortic Bodies. Pelvis. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17490668.001).
  • [ISSN] 0020-7292
  • [Journal-full-title] International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
  • [ISO-abbreviation] Int J Gynaecol Obstet
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


32. Shibata K, Kajiyama H, Yamamoto E, Terauchi M, Ino K, Nomura S, Nawa A, Kawai M, Kikkawa F: Effectiveness of preoperative concurrent chemoradiation therapy (CCRT) for locally advanced adenocarcinoma of cervix. Eur J Surg Oncol; 2009 Jul;35(7):768-72
Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effectiveness of preoperative concurrent chemoradiation therapy (CCRT) for locally advanced adenocarcinoma of cervix.
  • AIM: To determine the efficacy of preoperative concurrent chemoradiation therapy (CCRT) to improve the prognosis of locally advanced adenocarcinoma of the uterine cervix.
  • METHODS: Twenty-five patients with clinical stage IB2-IVB adenocarcinoma of the cervix were received preoperative CCRT.
  • The CCRT protocol included: external radiotherapy to the pelvis: 39.6 Gy; intra-arterial or intravenous infusion of 70 mg/m2 cisplatin, days 1 and 22; 24-h continuous intravenous infusion of 700 mg/m2 5-FU, days 1-4 and 22-25.
  • CONCLUSIONS: Preoperative CCRT improves the survival of patients with locally advanced adenocarcinoma of the cervix, with manageable toxicities.
  • [MeSH-major] Adenocarcinoma / therapy. Antineoplastic Agents / administration & dosage. Cisplatin / administration & dosage. Radiotherapy, Adjuvant. Uterine Cervical Neoplasms / therapy
  • [MeSH-minor] Adult. Chemotherapy, Adjuvant. Female. Gynecologic Surgical Procedures. Humans. Middle Aged. Neoadjuvant Therapy. Neoplasm Staging. Preoperative Care. Prognosis. Survival Analysis. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18722747.001).
  • [ISSN] 1532-2157
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


33. Martínez-Román S, Ramirez PT, Oh J, Viciedo MG, MacApinlac HA: Combined positron emission tomography and computed tomography for the detection of recurrent ovarian mucinous adenocarcinoma. Gynecol Oncol; 2005 Mar;96(3):888-91
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combined positron emission tomography and computed tomography for the detection of recurrent ovarian mucinous adenocarcinoma.
  • BACKGROUND: The role of combined positron emission tomography and computed tomography (PET-CT) in the diagnosis of recurrent ovarian mucinous adenocarcinoma is uncertain because of previous reports that PET has limited sensitivity in the detection of mucinous neoplasms.
  • Physical examination and transvaginal ultrasonography revealed a 12 x 13 cm cystic mass in the left side of the pelvis.
  • The diagnosis was FIGO stage IIIC well-differentiated ovarian mucinous adenocarcinoma.
  • CONCLUSION: PET-CT may identify clinically occult recurrent ovarian mucinous adenocarcinoma.
  • [MeSH-major] Adenocarcinoma, Mucinous / diagnosis. Adenocarcinoma, Mucinous / radionuclide imaging. Ovarian Neoplasms / diagnosis. Ovarian Neoplasms / radionuclide imaging

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15721446.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Fluorine Radioisotopes; 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


34. Carr S, Anderson C: Metastatic rectal adenocarcinoma in the external auditory canal. J Laryngol Otol; 2009 Mar;123(3):363-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic rectal adenocarcinoma in the external auditory canal.
  • OBJECTIVES: To present a rare case of rectal adenocarcinoma metastasising to the external auditory canal, in a patient in whom computed tomography staging of the abdomen, chest and pelvis was clear for metastatic disease.
  • CONCLUSIONS: Metastatic tumours to the external auditory canal are rare, with rectal adenocarcinoma being one of the rarest.
  • However, it is important that the external auditory canal is regarded as a potential site for metastasis, even when computed tomography staging is clear.
  • Metastatic tumour should be included in the differential diagnosis of a patient presenting with an ear mass.
  • [MeSH-major] Adenocarcinoma / secondary. Ear Canal. Ear Neoplasms / secondary. Rectal Neoplasms / pathology
  • [MeSH-minor] Humans. Male. Middle Aged. Neoplasm Staging. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18533051.001).
  • [ISSN] 1748-5460
  • [Journal-full-title] The Journal of laryngology and otology
  • [ISO-abbreviation] J Laryngol Otol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 7
  •  go-up   go-down


35. Hes O, Curík R, Mainer K, Michal M: Urothelial signet-ring cell carcinoma of the renal pelvis with collagenous spherulosis: a case report. Int J Surg Pathol; 2005 Oct;13(4):375-8
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Urothelial signet-ring cell carcinoma of the renal pelvis with collagenous spherulosis: a case report.
  • We present a unique case of urothelial carcinoma of the right renal pelvis.
  • The tumor was located in the renal pelvis with extension into the adjacent renal medulla and cortex.
  • No signs of intestinal type of metaplasia and adenocarcinoma, changes similar to the cystitis cystica or cystitis glandularis, were found in the tumor or in its vicinity.
  • [MeSH-major] Carcinoma, Signet Ring Cell / diagnosis. Carcinoma, Signet Ring Cell / pathology. Collagen / analysis. Kidney Neoplasms / diagnosis. Kidney Neoplasms / pathology
  • [MeSH-minor] Female. Humans. Immunohistochemistry. Keratins / metabolism. Kidney Pelvis / metabolism. Kidney Pelvis / pathology. Kidney Pelvis / ultrastructure. Microvilli / ultrastructure. Middle Aged. Urothelium / chemistry. Urothelium / pathology. Urothelium / ultrastructure

  • Genetic Alliance. consumer health - Signet ring cell carcinoma.
  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16273199.001).
  • [ISSN] 1066-8969
  • [Journal-full-title] International journal of surgical pathology
  • [ISO-abbreviation] Int. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 68238-35-7 / Keratins; 9007-34-5 / Collagen
  •  go-up   go-down


36. Kawaguchi H, Miyoshi N, Souda M, Maeda H, Kawashima H, Gejima K, Uchida K, Umekita Y, Yoshida H: Renal adenocarcinoma in a ferret. Vet Pathol; 2006 May;43(3):353-6
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Renal adenocarcinoma in a ferret.
  • Metastases were recognized in the lung, liver, greater omentum, right renal pelvis, and systemic lymph nodes.
  • On the basis of morphologic and immunohistochemical features, the tumor was diagnosed as a pleomorphic renal adenocarcinoma.
  • This type of neoplasm is very rare in all species and has never been reported in a ferret.
  • [MeSH-major] Adenocarcinoma / veterinary. Ferrets. Kidney Neoplasms / veterinary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16672582.001).
  • [ISSN] 0300-9858
  • [Journal-full-title] Veterinary pathology
  • [ISO-abbreviation] Vet. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


37. Wadhwa P, Kolla SB, Hemal AK: Laparoscopic en bloc partial cystectomy with bilateral pelvic lymphadenectomy for urachal adenocarcinoma. Urology; 2006 Apr;67(4):837-43
Genetic Alliance. consumer health - Urachal adenocarcinoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic en bloc partial cystectomy with bilateral pelvic lymphadenectomy for urachal adenocarcinoma.
  • INTRODUCTION: Surgical options for treating urachal adenocarcinoma include radical cystectomy and en bloc partial cystectomy with excision of the urachus and umbilectomy.
  • TECHNICAL CONSIDERATIONS: We performed the procedure in 3 patients with established urachal adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / surgery. Cystectomy / methods. Laparoscopy. Lymph Node Excision / methods. Urachus
  • [MeSH-minor] Adult. Female. Humans. Male. Middle Aged. Pelvis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16618570.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


38. Li H, Gou HY, Han JS, Li SM, Yang R, Qiao J: [Analysis of the diagnosis and treatment of cervical minimal deviation adenocarcinoma]. Zhonghua Zhong Liu Za Zhi; 2008 Oct;30(10):772-4
Hazardous Substances Data Bank. EPIRUBICIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Analysis of the diagnosis and treatment of cervical minimal deviation adenocarcinoma].
  • OBJECTIVE: To analyze the characteristics of cervical minimal deviation adenocarcinoma (MDA) and the methods of diagnosis and treatment.
  • Preoperative Pap smears showed adenocarcinoma in 3 cases (27.3%).
  • The diagnosis of MDA was confirmed in 8 cases by cervical punch biopsies (53.3%) and 2 cases by conization.
  • Four cases experienced recurrence in the vagina and pelvis at 2 years after operation.
  • CONCLUSION: Cervical minimal deviation adenocarcinoma is rare, with minimal deviation of cell shape from the normal cervical cells and difficult in diagnosis.
  • A deep biopsy or conization is necessary when punch biopsy is not sufficient for diagnosis.
  • Immunohistochemistry is helpful to make an accurate diagnosis.
  • Surgery is the first choice for cervical minimal deviation adenocarcinoma.
  • [MeSH-major] Adenocarcinoma. Cervix Uteri / pathology. Hysterectomy / methods. Uterine Cervical Neoplasms
  • [MeSH-minor] Actins / metabolism. Adult. Aged. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Carcinoembryonic Antigen / metabolism. Chemotherapy, Adjuvant. Cisplatin / administration & dosage. Conization. Epirubicin / administration & dosage. Female. Fluorouracil / administration & dosage. Follow-Up Studies. Humans. Middle Aged. Neoplasm Recurrence, Local. Neoplasm Staging. Papanicolaou Test. Radiotherapy, Adjuvant. Retrospective Studies. Survival Rate. Vaginal Smears


39. Al-Talib A, Gilbert L, Arseneau J: Endometrioid adenocarcinoma 13 years after total abdominal hysterectomy and bilateral salpingo-oophorectomy. Saudi Med J; 2008 Jul;29(7):1044-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endometrioid adenocarcinoma 13 years after total abdominal hysterectomy and bilateral salpingo-oophorectomy.
  • Malignant transformation is an infrequent complication of endometriosis.
  • Computed tomography of chest, pelvis, and abdomen, demonstrated right-sided pleural effusion and soft tissue mass in the pelvis.
  • Pleural effusion was tapped and biopsy from the peritoneal mass showed metastatic adenocarcinoma; immunohistochemistry findings favored endometrioid adenocarcinoma.
  • Unopposed estrogen stimulation may lead to premalignant or malignant transformation in the residual foci of endometriosis.

  • MedlinePlus Health Information. consumer health - Endometriosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18626539.001).
  • [ISSN] 0379-5284
  • [Journal-full-title] Saudi medical journal
  • [ISO-abbreviation] Saudi Med J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Saudi Arabia
  •  go-up   go-down


40. Fancher TT, Dudrick SJ, Palesty JA: Papillary adenocarcinoma of the urachus presenting as an umbilical mass. Conn Med; 2010 Jun-Jul;74(6):325-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Papillary adenocarcinoma of the urachus presenting as an umbilical mass.
  • A computerized tomography scan of the abdomen and pelvis suggested a large tumor extending from the umbilicus to the dome of the bladder with elements of tissue within the bladder consistent with a malignancy of either bladder or urachal origin.
  • The patient subsequently underwent a cystoscopic biopsy which was positive for papillary adenocarcinoma arising in a villous adenoma.
  • [MeSH-major] Adenocarcinoma, Papillary / pathology. Urachus / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20648839.001).
  • [ISSN] 0010-6178
  • [Journal-full-title] Connecticut medicine
  • [ISO-abbreviation] Conn Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


41. Nishimura N, Hachisuga T, Yokoyama M, Iwasaka T, Kawarabayashi T: Clinicopathologic analysis of the prognostic factors in women with coexistence of endometrioid adenocarcinoma in the endometrium and ovary. J Obstet Gynaecol Res; 2005 Apr;31(2):120-6
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathologic analysis of the prognostic factors in women with coexistence of endometrioid adenocarcinoma in the endometrium and ovary.
  • METHODS: Thirty-six patients with gross tumors confined to the pelvis and of endometrioid adenocarcinoma subtype in both the endometrium and ovary were selected from our file of 546 Japanese women with endometrial carcinoma.
  • CONCLUSION: When encountering women with coexisting endometrioid carcinoma in the endometrium and ovary with gross tumor limited to the pelvis, more attention should be paid to LVSI of the tumor of the uterus as a poor prognostic indicator.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Analysis of Variance. Female. Humans. Middle Aged. Neoplasm Invasiveness. Prognosis. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15771637.001).
  • [ISSN] 1341-8076
  • [Journal-full-title] The journal of obstetrics and gynaecology research
  • [ISO-abbreviation] J. Obstet. Gynaecol. Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


42. Azumi M, Hou K, Numata A, Taniguchi N, Saga Y, Hashimoto H, Kakizaki H: Case report of renal pelvic adenocarcinoma associated with a renal stone that produced carbohydrate antigen 125 and carbohydrate antigen 19-9. Hinyokika Kiyo; 2007 Sep;53(9):631-4
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Case report of renal pelvic adenocarcinoma associated with a renal stone that produced carbohydrate antigen 125 and carbohydrate antigen 19-9.
  • Pathological diagnosis was papillary adenocarcinoma of the renal pelvis with positive staining for carbohydrate antigen 125 (CA125) and carbohydrate antigen 19 9 (CA19-9).
  • Although papillary adenocarcinoma of the renal pelvis is extremely rare, the possibility of renal pelvic tumor should be kept in mind for patients who have a long-standing renal stone and hydronephrosis with irregularity at the renal pelvic wall.
  • [MeSH-major] Adenocarcinoma / immunology. CA-125 Antigen / analysis. CA-19-9 Antigen / analysis. Kidney Calculi / complications. Kidney Neoplasms / immunology. Kidney Pelvis

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17933139.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / CA-125 Antigen; 0 / CA-19-9 Antigen
  •  go-up   go-down


43. Klopp AH, Jhingran A, Ramondetta L, Lu K, Gershenson DM, Eifel PJ: Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation. Gynecol Oncol; 2009 Oct;115(1):6-11
Hazardous Substances Data Bank. CARBOPLATIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation.
  • OBJECTIVE: To evaluate treatment outcomes and patterns of recurrence in patients with node-positive (International Federation of Obstetrics and Gynecology stage IIIC) adenocarcinoma of the uterus without serous or clear cell differentiation.
  • METHODS: The records of 71 women who were treated for stage IIIC endometrial adenocarcinoma at our institution between 1984 and 2005 were reviewed.
  • In patients treated without regional RT, the most common site of relapse was the pelvis.
  • Patients with stage IIIC endometrial adenocarcinoma who underwent surgical staging followed by external beam irradiation had a high rate of cure.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Endometrial Neoplasms / radiotherapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Brachytherapy. Carboplatin / administration & dosage. Chemotherapy, Adjuvant. Cisplatin / administration & dosage. Female. Humans. Hysterectomy. Lymph Node Excision. Lymphatic Metastasis. Middle Aged. Neoplasm Recurrence, Local / pathology. Neoplasm Staging. Ovariectomy. Paclitaxel / administration & dosage. Radiotherapy, Adjuvant. Treatment Outcome

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. TAXOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19632709.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] BG3F62OND5 / Carboplatin; P88XT4IS4D / Paclitaxel; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


44. Zaghloul MS, El Baradie M, Nouh, Abdel-Fatah S, Taher A, Shalaan M: Prognostic index for primary adenocarcinoma of the urinary bladder. Gulf J Oncolog; 2007 Jul;(2):47-54
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic index for primary adenocarcinoma of the urinary bladder.
  • AIM: To determine the working independent prognostic factors and the prognostic index of adenocarcinoma of the urinary bladder.
  • PATIENTS AND METHODS: Two hundred and sixteen patients having adenocarcinoma of the urinary bladder were treated with radical cystectomy and pelvic lymphadenectomy with (82 patients) or without (134) postoperative radiotherapy.
  • Postoperative radiotherapy (PORT) was given to the whole pelvis in a dose of 50 Gy/25 fractions over 5 weeks, and started 4-10 weeks after surgery.
  • CONCLUSIONS: The identified prognostic indices with their prognostic group could be used not only as a predictor of disease-free survival but also as a good predictor for the need to add adjuvant therapy in adenocarcinoma of the urinary bladder.
  • [MeSH-major] Adenocarcinoma / diagnosis. Urinary Bladder Neoplasms / diagnosis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Combined Modality Therapy. Female. Humans. Male. Middle Aged. Neoplasm Staging. Postoperative Period. Prognosis. Radiotherapy Dosage. Radiotherapy, Adjuvant. Survival Rate. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20084724.001).
  • [ISSN] 2078-2101
  • [Journal-full-title] The Gulf journal of oncology
  • [ISO-abbreviation] Gulf J Oncolog
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Kuwait
  •  go-up   go-down


45. Yang YC, Lee ZY, Wu CC, Chen TC, Chang CL, Chen CP: CXCR4 expression is associated with pelvic lymph node metastasis in cervical adenocarcinoma. Int J Gynecol Cancer; 2007 May-Jun;17(3):676-86
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CXCR4 expression is associated with pelvic lymph node metastasis in cervical adenocarcinoma.
  • The aim of this study is to investigate the expression of CXCR4 receptor in cervical adenocarcinoma and related mechanisms involved in pelvic lymph node metastasis.
  • The HeLa cell (cervical adenocarcinoma-derived cell) line that expresses CXCR4 was used to study the interaction between the CXCR4 receptor and stromal cell-derived factor 1alpha (SDF-1alpha).
  • We conclude CXCR4 expression is associated with cervical adenocarcinoma cell migration and proliferation, and primary cervical adenocarcinoma cells expressing CXCR4 are significantly more likely to metastasize to pelvic lymph nodes.
  • [MeSH-major] Adenocarcinoma / pathology. Lymphatic Metastasis. Receptors, CXCR4 / metabolism. Uterine Cervical Neoplasms / pathology
  • [MeSH-minor] Adult. Cell Line, Tumor. Cell Movement / drug effects. Cell Proliferation / drug effects. Cell Survival / drug effects. Chemokine CXCL12. Chemokines, CXC / metabolism. Chemokines, CXC / pharmacology. Female. HeLa Cells. Humans. Lymph Nodes / metabolism. Middle Aged. Mitogen-Activated Protein Kinase 1 / metabolism. Mitogen-Activated Protein Kinase 3 / metabolism. Oncogene Protein v-akt / metabolism. Pelvis. U937 Cells

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17504381.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CXCL12 protein, human; 0 / Chemokine CXCL12; 0 / Chemokines, CXC; 0 / Receptors, CXCR4; EC 2.7.11.1 / Oncogene Protein v-akt; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 1; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 3
  •  go-up   go-down


46. Aizer AA, Yu JB, McKeon AM, Decker RH, Colberg JW, Peschel RE: Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma. Int J Radiat Oncol Biol Phys; 2009 Dec 1;75(5):1344-9
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma.
  • PURPOSE: To determine whether whole pelvic radiotherapy (WPRT) or prostate-only radiotherapy (PORT) yields improved biochemical disease-free survival (BDFS) in patients with advanced or aggressive prostate adenocarcinoma.
  • METHODS AND MATERIALS: Between 2000 and 2007, a consecutive sample of 277 patients with prostate adenocarcinoma and at least a 15% likelihood of lymph node involvement who had undergone WPRT (n = 68) or PORT (n = 209) at two referral centers was analyzed.
  • CONCLUSION: WPRT may yield improved BDFS in patients with advanced or aggressive prostate adenocarcinoma, but results in a greater incidence of acute toxicity.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Lymphatic Irradiation / adverse effects. Prostate-Specific Antigen / blood. Prostatic Neoplasms / radiotherapy
  • [MeSH-minor] Aged. Disease-Free Survival. Follow-Up Studies. Gastrointestinal Tract / radiation effects. Humans. Lymphatic Metastasis / radiotherapy. Male. Middle Aged. Multivariate Analysis. Pelvis. Radiotherapy Dosage. Radiotherapy, Intensity-Modulated / adverse effects. Radiotherapy, Intensity-Modulated / methods. Retrospective Studies. Urogenital System / radiation effects

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer Screening.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19464821.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 3.4.21.77 / Prostate-Specific Antigen
  •  go-up   go-down


47. Yabushita H, Kanyama K, Sekiya R, Noguchi M, Wakatsuki A: Clear-cell adenocarcinoma of the uterine cervix in a 17-year-old adolescent. Int J Clin Oncol; 2008 Dec;13(6):552-4
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clear-cell adenocarcinoma of the uterine cervix in a 17-year-old adolescent.
  • This report describes the case of the youngest Japanese person to be diagnosed with endocervical clearcell adenocarcinoma.
  • The cytological finding of the uterine cervix was positive for malignancy, and the histological diagnosis by punch biopsy was clear-cell adenocarcinoma of the uterine cervix.
  • The pathological diagnosis was clear-cell adenocarcinoma of the cervix (PT1b1NR0M0).
  • [MeSH-major] Adenocarcinoma, Clear Cell / pathology. Uterine Cervical Neoplasms / pathology
  • [MeSH-minor] Adolescent. Female. Humans. Hysterectomy. Lymph Node Excision. Pelvis

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1970 Apr;25(4):745-57 [5443099.001]
  • [Cites] Int J Clin Oncol. 2003 Dec;8(6):399-404 [14663645.001]
  • [Cites] Cancer. 1997 Jun 1;79(11):2229-36 [9179071.001]
  • [Cites] Am J Pathol. 2000 Oct;157(4):1055-62 [11021808.001]
  • [Cites] Obstet Gynecol. 1974 May;43(5):640-4 [4822647.001]
  • [Cites] N Engl J Med. 1971 Aug 12;285(7):390-2 [5556578.001]
  • [Cites] Semin Diagn Pathol. 1997 Nov;14(4):233-9 [9383823.001]
  • [Cites] N Engl J Med. 1971 Apr 15;284(15):878-81 [5549830.001]
  • [Cites] Br Med J. 1978 Jun 17;1(6127):1588-90 [656822.001]
  • [Cites] N Engl J Med. 1987 Feb 26;316(9):514-6 [3807995.001]
  • [Cites] J Reprod Med. 1983 Feb;28(2):137-46 [6834354.001]
  • [Cites] Cancer. 1996 Feb 1;77(3):507-13 [8630958.001]
  • [Cites] Obstet Gynecol. 1973 Apr;41(4):494-500 [4696964.001]
  • (PMID = 19093185.001).
  • [ISSN] 1341-9625
  • [Journal-full-title] International journal of clinical oncology
  • [ISO-abbreviation] Int. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


48. Nagai Y, Inamine M, Hirakawa M, Kamiyama K, Ogawa K, Toita T, Murayama S, Aoki Y: Postoperative whole abdominal radiotherapy in clear cell adenocarcinoma of the ovary. Gynecol Oncol; 2007 Dec;107(3):469-73
Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Postoperative whole abdominal radiotherapy in clear cell adenocarcinoma of the ovary.
  • OBJECTIVES: The aim of this study was to clarify the efficacy of postoperative whole abdominal radiotherapy (WAR) for ovarian clear cell adenocarcinoma (OCCA).
  • The planned WAR comprised external beam radiotherapy (EBRT) to the entire abdominal cavity with 22.0-24.0 Gy/22-24 fractions followed by EBRT to the pelvis with 23.4-21.6 Gy/12-13 fractions.
  • [MeSH-major] Adenocarcinoma, Clear Cell / radiotherapy. Ovarian Neoplasms / radiotherapy
  • [MeSH-minor] Adult. Aged. Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Cisplatin / administration & dosage. Combined Modality Therapy. Cyclophosphamide / administration & dosage. Doxorubicin / administration & dosage. Female. Humans. Middle Aged. Neoplasm Recurrence, Local / pathology. Neoplasm Staging. Postoperative Care. Radiotherapy / adverse effects

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17765295.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; Q20Q21Q62J / Cisplatin; CISCA protocol
  •  go-up   go-down


49. Grillo-Ruggieri F, Mantello G, Berardi R, Cardinali M, Fenu F, Iovini G, Montisci M, Fabbietti L, Marmorale C, Guerrieri M, Saba V, Bearzi I, Mattioli R, Bonsignori M, Cascinu S: Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy. Dis Colon Rectum; 2007 Oct;50(10):1594-603
Hazardous Substances Data Bank. FLUOROURACIL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy.
  • PURPOSE: The aim of this study was to evaluate downstaging as primary end point, and progression-free survival and overall survival as secondary end points, in rectal adenocarcinoma patients treated with preoperative chemoradiation.
  • METHODS: One hundred and thirty-six extraperitoneal adenocarcinoma patients (33 low rectum T2, 74 T3, 29 T4 [without sacral invasion], 25 with mucinous subtype) were treated with posterior pelvis preoperative radiotherapy (5040 cGy total dose, 180 cGy/fr, 5 fr/w, 10-15 MV linac X-rays) and concomitant 5-fluorouracil-based chemotherapy.
  • There were no significant differences in overall survival and progression-free survival between adenocarcinoma and mucinous subtype.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Adenocarcinoma, Mucinous / therapy. Rectal Neoplasms / pathology. Rectal Neoplasms / therapy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Antimetabolites, Antineoplastic / therapeutic use. Chemotherapy, Adjuvant. Digestive System Surgical Procedures. Disease-Free Survival. Female. Fluorouracil / therapeutic use. Humans. Male. Middle Aged. Neoplasm Staging. Radiotherapy, Adjuvant. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17846841.001).
  • [ISSN] 0012-3706
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; U3P01618RT / Fluorouracil
  •  go-up   go-down


50. Quadros CA, Lopes A, Araújo I, Fahel F, Bacellar MS, Dias CS: Retroperitoneal and lateral pelvic lymphadenectomy mapped by lymphoscintigraphy and blue dye for rectal adenocarcinoma staging: preliminary results. Ann Surg Oncol; 2006 Dec;13(12):1617-21
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Retroperitoneal and lateral pelvic lymphadenectomy mapped by lymphoscintigraphy and blue dye for rectal adenocarcinoma staging: preliminary results.
  • BACKGROUND: Total mesorectal excision (TME) is the standard surgical choice for rectal adenocarcinoma.
  • METHODS: Thirty rectal adenocarcinoma patients were submitted to RLPL, with RLPN mapping using technetium (Tc 99 m) and patent blue, having nodes examined histopathologically and immunohistochemically.
  • [MeSH-major] Adenocarcinoma / radiography. Lymph Node Excision / methods. Lymph Nodes / radionuclide imaging. Pelvis / surgery. Rectal Neoplasms / radionuclide imaging
  • [MeSH-minor] Adult. Aged. Coloring Agents. Female. Humans. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Staging. Radiopharmaceuticals. Retroperitoneal Space. Rosaniline Dyes. Sensitivity and Specificity. Sentinel Lymph Node Biopsy. Technetium

  • Hazardous Substances Data Bank. C.I. FOOD BLUE 3 .
  • Hazardous Substances Data Bank. TECHNETIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17009148.001).
  • [ISSN] 1068-9265
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Coloring Agents; 0 / Radiopharmaceuticals; 0 / Rosaniline Dyes; 129-17-9 / patent blue violet; 7440-26-8 / Technetium
  •  go-up   go-down


51. Mahdavi A, Shamshirsaz AA, Peiretti M, Zakashansky K, Idrees MT, Nezhat F: Laparoscopic management of vaginal clear cell adenocarcinoma arising in pelvic endometriosis: case report and literature review. J Minim Invasive Gynecol; 2006 May-Jun;13(3):237-41
MedlinePlus Health Information. consumer health - Vaginal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic management of vaginal clear cell adenocarcinoma arising in pelvic endometriosis: case report and literature review.
  • Vaginal clear cell adenocarcinoma arising from pelvic endometriosis has not been reported in the literature.
  • We report a case of a 50-year-old woman with stage I clear cell adenocarcinoma of the vagina who was found to have endometriosis adjacent to the vaginal tumor.
  • [MeSH-major] Adenocarcinoma, Clear Cell / surgery. Endometriosis / complications. Endometriosis / surgery. Vaginal Neoplasms / surgery
  • [MeSH-minor] Combined Modality Therapy. Female. Gynecologic Surgical Procedures. Humans. Laparoscopy. Middle Aged. Neoplasm Staging. Pelvis

  • Genetic Alliance. consumer health - Endometriosis.
  • MedlinePlus Health Information. consumer health - Endometriosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16698533.001).
  • [ISSN] 1553-4650
  • [Journal-full-title] Journal of minimally invasive gynecology
  • [ISO-abbreviation] J Minim Invasive Gynecol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 24
  •  go-up   go-down


52. Mason AC, Azari KK, Farkas LM, Duvvuri U, Myers EN: Metastatic adenocarcinoma of the colon presenting as a mass in the mandible. Head Neck; 2005 Aug;27(8):729-32

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic adenocarcinoma of the colon presenting as a mass in the mandible.
  • BACKGROUND: Metastatic adenocarcinoma of the colon is a frequently encountered medical situation.
  • Metastasis to the mandible from adenocarcinoma of the colon is very unusual and rarely reported.
  • We report the case of a 73-year-old man with metastatic adenocarcinoma to the mandible.
  • CT scans of the abdomen and pelvis revealed a 5-cm mass in the sigmoid colon with metastases to the liver.
  • RESULTS: A biopsy of the mass in the mandible was performed, and metastatic adenocarcinoma of colonic origin was diagnosed.
  • Colonoscopy and biopsy of the colonic mass substantiated that the sigmoid colon was the primary site of the cancer.
  • CONCLUSIONS: Although rare, metastatic adenocarcinoma from the colon to the mandible and parotid area should be included in the differential diagnosis of masses in this area.
  • After analysis of our case and a review of the literature, we conclude that metastasis from adenocarcinoma of the colon is quite rare and represents incurable disseminated disease.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / secondary. Mandibular Neoplasms / diagnosis. Mandibular Neoplasms / secondary. Sigmoid Neoplasms / pathology
  • [MeSH-minor] Aged. Biopsy. Colon, Sigmoid / radiography. Cranial Fossa, Middle. Diagnosis, Differential. Endoscopy. Fatal Outcome. Humans. Liver Neoplasms / secondary. Male. Mandible / pathology. Mandible / radiography. Pterygoid Muscles. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 Wiley Periodicals, Inc.
  • (PMID = 15920751.001).
  • [ISSN] 1043-3074
  • [Journal-full-title] Head & neck
  • [ISO-abbreviation] Head Neck
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


53. Rafailidis SF, Ballas KD, Symeonidis N, Pavlidis TE, Emoniotou E, Psarras K, Pantzaki A, Marakis GN, Sakadamis AK: Pelvic malakoplakia simulating recurrence of rectal adenocarcinoma: report of a case. Tech Coloproctol; 2009 Mar;13(1):79-81
Genetic Alliance. consumer health - Malakoplakia.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pelvic malakoplakia simulating recurrence of rectal adenocarcinoma: report of a case.
  • Rarity of the disease and wide variety of clinical presentation makes its diagnosis very challenging.
  • We report herein the case of a 66-year-old woman who, having undergone lower anterior resection for rectal adenocarcinoma 3 and a half years ago, presented with urinary frequency and dull abdominal pain.
  • [MeSH-major] Adenocarcinoma / surgery. Malacoplakia / diagnosis. Neoplasm Recurrence, Local / diagnosis. Pelvis / pathology. Rectal Neoplasms / surgery
  • [MeSH-minor] Aged. Colonoscopy. Diagnosis, Differential. Female. Humans. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Histopathology. 1988 Jun;12(6):672-5 [3417248.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1995 Jul 15;32(4):1025-9 [7607922.001]
  • [Cites] J Urol. 1995 Aug;154(2 Pt 1):523-4 [7609124.001]
  • [Cites] J Urol. 1981 Feb;125(2):139-46 [7009885.001]
  • [Cites] Ann Urol (Paris). 2002 Dec;36(6):388-91 [12611142.001]
  • [Cites] Dis Colon Rectum. 2001 Sep;44(9):1371-5 [11584219.001]
  • [Cites] Int J Gynecol Pathol. 2001 Oct;20(4):403-6 [11603228.001]
  • [Cites] Changgeng Yi Xue Za Zhi. 1998 Sep;21(3):318-22 [9849014.001]
  • [Cites] J Pathol. 1983 Aug;140(4):275-330 [6308195.001]
  • [Cites] Arch Intern Med. 1996 Mar 11;156(5):577-83 [8604965.001]
  • (PMID = 18679567.001).
  • [ISSN] 1128-045X
  • [Journal-full-title] Techniques in coloproctology
  • [ISO-abbreviation] Tech Coloproctol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


54. Bazil MK, Henshaw RM, Werner A, Lowe EJ: Aggressive Digital Papillary Adenocarcinoma in a 15-year-old Female. J Pediatr Hematol Oncol; 2006 Aug;28(8):529-30

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aggressive Digital Papillary Adenocarcinoma in a 15-year-old Female.
  • Aggressive digital papillary adenocarcinoma is a rare neoplasm of eccrine sweat gland origin that typically presents as a mass on a finger, toe, or the adjacent skin.
  • We report a case of an aggressive digital papillary adenocarcinoma of the right second toe in a 15-year-old white female.
  • A metastatic work-up, computed tomography of the chest, abdomen, pelvis, and a bone scan, was negative.
  • To our knowledge, this is the youngest reported case of an aggressive digital papillary adenocarcinoma.
  • [MeSH-major] Adenocarcinoma, Papillary / pathology. Fingers / pathology. Sweat Gland Neoplasms / pathology
  • [MeSH-minor] Adolescent. Diagnosis, Differential. Female. Humans. Rare Diseases. Sentinel Lymph Node Biopsy / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16912593.001).
  • [ISSN] 1077-4114
  • [Journal-full-title] Journal of pediatric hematology/oncology
  • [ISO-abbreviation] J. Pediatr. Hematol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


55. Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH: Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix. Br J Cancer; 2010 Jun 8;102(12):1692-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix.
  • BACKGROUND: To determine the prognostic factors and treatment outcomes of patients with early-stage adenocarcinoma (AdCa) of uterine cervix who underwent radical hysterectomy (RH).
  • Recurrence outside the pelvis was more frequent in AdCa than in those with SCCa (75 vs 57.8%, P=0.084).
  • [MeSH-major] Adenocarcinoma / surgery. Hysterectomy / methods. Uterine Cervical Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Carcinoma, Squamous Cell / mortality. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / surgery. Disease-Free Survival. Female. Humans. Lymphatic Metastasis. Middle Aged. Neoplasm Recurrence, Local / pathology. Prognosis. Recurrence. Treatment Outcome


56. Kitley CA, Mosier AD, Keylock J, Nguyen D: Malignant priapism secondary to adenocarcinoma of the prostate. BMJ Case Rep; 2010;2010
MedlinePlus Health Information. consumer health - Prostate Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant priapism secondary to adenocarcinoma of the prostate.
  • After an initial clinical workup, an MRI was performed of the pelvis for further evaluation of the patient's condition which demonstrated metastatic lesions within his corpora cavernosa.
  • [MeSH-major] Adenocarcinoma / diagnosis. Penile Neoplasms / secondary. Priapism / etiology. Prostatic Neoplasms / diagnosis
  • [MeSH-minor] Aged. Biopsy, Large-Core Needle. Bone Neoplasms / diagnosis. Bone Neoplasms / secondary. Diagnosis, Differential. Disease Progression. Fatal Outcome. Follow-Up Studies. Humans. Image Interpretation, Computer-Assisted. Liver Neoplasms / diagnosis. Liver Neoplasms / secondary. Lymphatic Metastasis / pathology. Magnetic Resonance Imaging. Male. Neoplasm Invasiveness. Palliative Care. Penis / pathology. Prostate / pathology. Tomography, X-Ray Computed. Urinary Bladder / pathology

  • Genetic Alliance. consumer health - Priapism.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiographics. 2001 Oct;21 Spec No:S283-98; discussion S298-9 [11598264.001]
  • [Cites] J Androl. 2003 Jul-Aug;24(4):499-500 [12826689.001]
  • [Cites] Radiol Clin North Am. 2004 Mar;42(2):427-43 [15136026.001]
  • [Cites] Eur Urol. 1987;13(5):351-2 [3315692.001]
  • [Cites] Urol Int. 1994;52(1):52-4 [8140683.001]
  • [Cites] Urology. 1998 Feb;51(2):324-6 [9495721.001]
  • [Cites] J Surg Oncol. 1998 May;68(1):51-9 [9610664.001]
  • [Cites] Urol Clin North Am. 2007 Nov;34(4):631-42, viii [17983902.001]
  • (PMID = 22789733.001).
  • [ISSN] 1757-790X
  • [Journal-full-title] BMJ case reports
  • [ISO-abbreviation] BMJ Case Rep
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3028547
  •  go-up   go-down


57. Kurosaka S, Irie A, Mizoguchi H, Okuno N, Iwabuchi K, Baba S: Advanced clear-cell adenocarcinoma of the bladder successfully treated by radical surgery with adjuvant chemoradiotherapy. Int J Clin Oncol; 2005 Oct;10(5):362-5
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Advanced clear-cell adenocarcinoma of the bladder successfully treated by radical surgery with adjuvant chemoradiotherapy.
  • Histopathological examination of the biopsy specimens showed clear-cell adenocarcinoma.
  • Macroscopically, the tumor had arisen from the trigone of the bladder, and histopathological examination of the tumor revealed adenocarcinoma exhibiting solid clear cells with glandular and papillary patterns.
  • [MeSH-major] Adenocarcinoma, Clear Cell / drug therapy. Adenocarcinoma, Clear Cell / surgery. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Urinary Bladder Neoplasms / surgery
  • [MeSH-minor] Chemotherapy, Adjuvant. Cystectomy. Female. Humans. Lymph Node Excision. Middle Aged. Pelvis. Urethra / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Urol. 2002 Aug;9(8):467-9 [12225345.001]
  • [Cites] Urol Int. 2003;71(2):228-30 [12890970.001]
  • [Cites] Eur J Gynaecol Oncol. 1996;17(1):13-6 [8750509.001]
  • [Cites] Cancer Lett. 2001 Jan 10;162(1):39-48 [11121861.001]
  • [Cites] Mod Pathol. 1993 Mar;6(2):225-8 [8483895.001]
  • [Cites] J Urol. 1968 Oct;100(4):466-9 [5677385.001]
  • [Cites] Histopathology. 1990 Jun;16(6):601-4 [2376401.001]
  • [Cites] Urology. 1984 Mar;23(3):303-4 [6199882.001]
  • [Cites] J Urol. 1990 Jan;143(1):122-5 [2294240.001]
  • (PMID = 16247666.001).
  • [ISSN] 1341-9625
  • [Journal-full-title] International journal of clinical oncology
  • [ISO-abbreviation] Int. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


58. Spurgeon JM, Cotlar AM: Cytoreductive surgery in the management of malignant ascites from adenocarcinoma of unknown primary (ACUP). Curr Surg; 2005 Sep-Oct;62(5):500-3
MedlinePlus Health Information. consumer health - Palliative Care.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cytoreductive surgery in the management of malignant ascites from adenocarcinoma of unknown primary (ACUP).
  • A case report is presented of a 62-year-old man with adenocarcinoma of unknown primary (ACUP) who was admitted with massive ascites from intraperitoneal carcinomatosis secondary to a gastrointestinal tract malignancy.
  • A computed tomography scan of the abdomen and pelvis confirmed extensive neoplasm.
  • [MeSH-major] Adenocarcinoma / therapy. Chemotherapy, Cancer, Regional Perfusion / methods. Neoplasm Invasiveness / pathology. Neoplasms, Unknown Primary / pathology. Palliative Care. Peritoneal Neoplasms / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16125606.001).
  • [ISSN] 0149-7944
  • [Journal-full-title] Current surgery
  • [ISO-abbreviation] Curr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


59. Kayacan O, Karnak D, Ayşe Can B, Dizbay Sak S, Beder S: Gastric signet-ring cell adenocarcinoma presenting with left arm deep-vein thrombosis and bilateral chylothorax. Clin Appl Thromb Hemost; 2008 Oct;14(4):476-80
MedlinePlus Health Information. consumer health - Stomach Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gastric signet-ring cell adenocarcinoma presenting with left arm deep-vein thrombosis and bilateral chylothorax.
  • Whole body bone scintigraphy showed bone metastases on left humerus, right femur, and pelvis.
  • Pleural fluid cytology showed similar malignant cells.
  • The patient was diagnosed as gastric signet-ring cell adenocarcinoma with endobronchial, mammary, ovarian, pleural, pericardial, peritoneal, and osteal metastases.

  • Genetic Alliance. consumer health - Thrombosis.
  • MedlinePlus Health Information. consumer health - Deep Vein Thrombosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18263634.001).
  • [ISSN] 1076-0296
  • [Journal-full-title] Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • [ISO-abbreviation] Clin. Appl. Thromb. Hemost.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


60. Anscher MS, Clough R, Robertson CN, Prosnitz LR, Dahm P, Walther P, Donatucci CF, Albala DM, Febbo P, George DJ, Sun L, Moul JW: Timing and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate. Prostate Cancer Prostatic Dis; 2006;9(3):254-60
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Timing and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate.
  • Between 1970 and 1983, 159 patients underwent RP for newly diagnosed adenocarcinoma of the prostate and were found to have positive surgical margins, extracapsular extension and/or seminal vesicle invasion.
  • The RT group generally received 45-50 Gy to the whole pelvis, then a boost to the prostate bed (total dose of 55-65 Gy).
  • [MeSH-major] Adenocarcinoma / pathology. Adenocarcinoma / radiotherapy. Prostatic Neoplasms / pathology. Prostatic Neoplasms / radiotherapy
  • [MeSH-minor] Adult. Aged. Antineoplastic Agents, Hormonal / therapeutic use. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Disease-Free Survival. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / drug therapy. Neoplasm Recurrence, Local / mortality. Neoplasm Recurrence, Local / radiotherapy. Neoplasm Staging. Pelvis / radiation effects. Prostatectomy / methods. Radiation Dosage. Radiotherapy, Adjuvant. Retrospective Studies. Survival Analysis. Time Factors. Treatment Failure

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16880828.001).
  • [ISSN] 1365-7852
  • [Journal-full-title] Prostate cancer and prostatic diseases
  • [ISO-abbreviation] Prostate Cancer Prostatic Dis.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Hormonal
  •  go-up   go-down


61. Tu WH, Jensen K, Freiha F, Liao JC: A case of prostatic adenocarcinoma recurrence presenting as ductal carcinoma of the prostate. Nat Clin Pract Urol; 2008 Jan;5(1):55-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of prostatic adenocarcinoma recurrence presenting as ductal carcinoma of the prostate.
  • He had been diagnosed with locally invasive adenocarcinoma of the prostate 10 years previously and treated with neoadjuvant hormonal and external beam radiation therapies.
  • Because of the patient's rising PSA level, he had been started on goserelin 6 years after this diagnosis and bicalutamide 6 months before the current presentation.
  • DIAGNOSIS: The patient underwent transurethral resection of the prostate.
  • Staging with bone scan and CT of the abdomen and pelvis demonstrated multi-focal bony metastasis.
  • [MeSH-major] Carcinoma, Ductal / diagnosis. Neoplasm Recurrence, Local. Prostatic Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18185514.001).
  • [ISSN] 1743-4289
  • [Journal-full-title] Nature clinical practice. Urology
  • [ISO-abbreviation] Nat Clin Pract Urol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


62. Petrou A, Papalambros A, Katsoulas N, Bramis K, Evangelou K, Felekouras E: Primary appendiceal mucinous adenocarcinoma alongside with situs inversus totalis: a unique clinical case. World J Surg Oncol; 2010;8:49
Genetic Alliance. consumer health - Situs inversus.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary appendiceal mucinous adenocarcinoma alongside with situs inversus totalis: a unique clinical case.
  • INTRODUCTION: Mucinous adenocarcinoma is a rare neoplasm of the gastrointestinal tract and one of the three major histological subtypes of the primary appendiceal adenocarcinoma.
  • The most common type of presentation is that of acute appendicitis and the diagnosis is usually occurred after appendectomy.
  • The accurate preoperative diagnosis and management of the above condition represents a real challenge when uncommon anatomic anomalies such intestinal malrotation and situs inversus take place.
  • Both preoperative US and CT scan of the abdomen and pelvis declared situs inversus, with a characteristic thickening in its wall, appendix situated in the left lower quadrant of the abdomen.
  • These findings reached to the diagnosis of acute appendicitis with situs inversus and a standard appendicectomy was performed.
  • Pathologic evaluation established primary mucinous adenocarcinoma of the appendix and three months afterwards the patient underwent a subsequent extended left hemicolectomy.
  • CONCLUSION: In conclusion, the occurrence of primary appendiceal mucinous adenocarcinoma along with situs inversus, definitely accounts as a unique clinical case.
  • Even synchronous manifestation of primary mucinous adenocarcinoma of the appendix and situs inversus totalis represents an unusual anatomo-pathological entity, all physicians should be familiar having the knowledge to make an appropriate and accurate diagnosis that will lead to prompt and correct treatment.
  • [MeSH-major] Adenocarcinoma, Mucinous / complications. Appendiceal Neoplasms / complications. Situs Inversus / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Surg Oncol. 2001 Dec;8(10):787-95 [11776492.001]
  • [Cites] Oncol Rep. 2008 Sep;20(3):517-23 [18695900.001]
  • [Cites] Minerva Chir. 2002 Oct;57(5):695-8 [12370673.001]
  • [Cites] Br J Surg. 2004 Mar;91(3):304-11 [14991630.001]
  • [Cites] Dis Colon Rectum. 2004 Apr;47(4):474-80 [14978617.001]
  • [Cites] Am Surg. 2004 Jul;70(7):593-9 [15279181.001]
  • [Cites] Ann Surg. 1976 Jan;183(1):53-7 [1247301.001]
  • [Cites] Am J Surg. 1994 Dec;168(6):685-7 [7978019.001]
  • [Cites] Br J Surg. 1995 Mar;82(3):299-306 [7795991.001]
  • [Cites] Dis Colon Rectum. 1995 Aug;38(8):848-52 [7634979.001]
  • [Cites] Am J Proctol. 1963 Dec;14:265-81 [14098730.001]
  • [Cites] Lancet Oncol. 2006 Jan;7(1):69-76 [16389186.001]
  • [Cites] Ann Surg Oncol. 2006 May;13(5):624-34 [16538401.001]
  • [Cites] Br J Surg. 2006 Jul;93(7):783-92 [16775823.001]
  • [Cites] Am J Cardiol. 2007 Jul 15;100(2):305-9 [17631088.001]
  • [Cites] Ann Surg Oncol. 2008 Jan;15(1):125-33 [18030535.001]
  • [Cites] Ann Surg Oncol. 2008 Feb;15(2):526-34 [18043976.001]
  • [Cites] Am J Health Syst Pharm. 2008 Jun 1;65(11 Suppl 4):S3-7; quiz S22-4 [18499888.001]
  • [Cites] Ann Surg Oncol. 2008 Aug;15(8):2137-45 [18493824.001]
  • [Cites] Jpn J Clin Oncol. 2008 Jul;38(7):493-6 [18567598.001]
  • [Cites] Cancer. 2002 Jun 15;94(12):3307-12 [12115365.001]
  • (PMID = 20525349.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2894825
  •  go-up   go-down


63. Wong NY, Koh PK, Eu KW: A novel method of dealing with a large rectal enterotomy in an irradiated pelvis. Tech Coloproctol; 2007 Dec;11(4):350-2

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A novel method of dealing with a large rectal enterotomy in an irradiated pelvis.
  • Subsequent laparotomy and adhesiolysis resulted in a large defect at the previous anastomotic site.
  • [MeSH-major] Adenocarcinoma / diagnostic imaging. Colectomy / methods. Colon / surgery. Pelvis / radiation effects. Rectal Neoplasms / radiotherapy. Rectum / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dig Surg. 2000;17(3):216-8 [10867452.001]
  • [Cites] Br J Surg. 1997 Aug;84(8):1130-5 [9278661.001]
  • [Cites] Br J Surg. 1989 Jun;76(6):605-6 [2758269.001]
  • [Cites] Am J Surg. 2001 Apr;181(4):309-12 [11438264.001]
  • [Cites] Dis Colon Rectum. 1999 Mar;42(3):403-18 [10223765.001]
  • [Cites] N Engl J Med. 1994 Aug 25;331(8):502-7 [8041415.001]
  • (PMID = 18209949.001).
  • [ISSN] 1123-6337
  • [Journal-full-title] Techniques in coloproctology
  • [ISO-abbreviation] Tech Coloproctol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


64. Sert B: Robotic port-site and pelvic recurrences after robot-assisted laparoscopic radical hysterectomy for a stage IB1 adenocarcinoma of the cervix with negative lymph nodes. Int J Med Robot; 2010 Jun;6(2):132-5
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Robotic port-site and pelvic recurrences after robot-assisted laparoscopic radical hysterectomy for a stage IB1 adenocarcinoma of the cervix with negative lymph nodes.
  • BACKGROUND: Port-site metastasis (PSM) following minimally invasive surgery for gynaecological cancer has been recognized as a potential problem over the last two decades.
  • METHODS: A 60 year-old woman with stage Ib1 adenocarcinoma of the cervix was treated with radical hysterectomy, bilateral salpingo-oophorectomy and bilateral pelvic lymph node dissection, using robot-assisted laparoscopy.
  • During the routine recurrence work-up, we found an 8 mm robotic port-site metastasis (PSM) on the abdominal computed tomography (CT) scan.
  • CONCLUSION: This is the first case report emphasizing the risk of PSM and early pelvic recurrences in robot-assisted laparoscopic radical hysterectomy and bilateral pelvic lymph node dissection for an early-stage cervical adenocarcinoma patient with negative lymph nodes, histologically examined by immunohistochemical ultrastaging.
  • [MeSH-major] Adenocarcinoma / secondary. Adenocarcinoma / surgery. Hysterectomy / methods. Uterine Cervical Neoplasms / pathology. Uterine Cervical Neoplasms / surgery
  • [MeSH-minor] Adnexa Uteri / pathology. Adnexa Uteri / surgery. Amputation. Endometrial Neoplasms / pathology. Endometrial Neoplasms / secondary. Endometrial Neoplasms / surgery. Female. Follow-Up Studies. Gynecologic Surgical Procedures. Humans. Laparoscopy / methods. Lymph Node Excision / methods. Lymph Nodes / pathology. Lymph Nodes / surgery. Middle Aged. Neoplasm Staging. Pelvis / pathology. Pelvis / surgery. Recurrence. Time Factors. Treatment Outcome


65. Sanghera P, Ho K, Muscroft T, Hartley A: Neoadjuvant chemotherapy enables R0 resection of locally advanced rectal cancer in a patient with a previously irradiated pelvis. Br J Radiol; 2007 Aug;80(956):e170-2
Hazardous Substances Data Bank. FLUOROURACIL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neoadjuvant chemotherapy enables R0 resection of locally advanced rectal cancer in a patient with a previously irradiated pelvis.
  • We present a case where radiotherapy was contraindicated as the patient had previously been irradiated to a radical dose for prostatic adenocarcinoma.
  • [MeSH-minor] Adenocarcinoma / radiotherapy. Aged. Capecitabine. Carcinoma, Transitional Cell / radiotherapy. Colonic Pouches. Deoxycytidine / administration & dosage. Deoxycytidine / analogs & derivatives. Fluorouracil / administration & dosage. Fluorouracil / analogs & derivatives. Humans. Magnetic Resonance Imaging. Male. Organoplatinum Compounds / administration & dosage. Prostatic Neoplasms / radiotherapy. Urinary Bladder Neoplasms / radiotherapy

  • Genetic Alliance. consumer health - Rectal Cancer.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17762049.001).
  • [ISSN] 1748-880X
  • [Journal-full-title] The British journal of radiology
  • [ISO-abbreviation] Br J Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Organoplatinum Compounds; 04ZR38536J / oxaliplatin; 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; U3P01618RT / Fluorouracil
  •  go-up   go-down


66. Kato M, Onishi T, Hoshina A, Yabana T: Successful treatment with paclitaxel/carboplatin chemotherapy in advanced adenocarcinoma of the urinary tract producing carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 125. Urol Int; 2010;84(1):116-8
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Successful treatment with paclitaxel/carboplatin chemotherapy in advanced adenocarcinoma of the urinary tract producing carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 125.
  • Primary adenocarcinoma of the urinary tract producing tumor markers is extremely rare.
  • We report 2 cases of advanced adenocarcinoma of the urinary tract producing carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9) and carbohydrate antigen 125 (CA125), which were completely resected after induction chemotherapy with paclitaxel and carboplatin.
  • Patient 1 was a 72-year-old woman with adenocarcinoma of the right renal pelvis and ureter.
  • Patient 2 was a 73-year-old woman with adenocarcinoma of the bladder.
  • [MeSH-major] Adenocarcinoma / drug therapy. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. CA-125 Antigen / biosynthesis. CA-19-9 Antigen / biosynthesis. Carboplatin / administration & dosage. Carcinoembryonic Antigen / biosynthesis. Paclitaxel / administration & dosage. Urinary Bladder Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • Hazardous Substances Data Bank. TAXOL .
  • Hazardous Substances Data Bank. CARBOPLATIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 S. Karger AG, Basel.
  • (PMID = 20173382.001).
  • [ISSN] 1423-0399
  • [Journal-full-title] Urologia internationalis
  • [ISO-abbreviation] Urol. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / CA-125 Antigen; 0 / CA-19-9 Antigen; 0 / Carcinoembryonic Antigen; BG3F62OND5 / Carboplatin; P88XT4IS4D / Paclitaxel
  •  go-up   go-down


67. D'Hondt M, De Hondt G, Malisse P, Vanden Boer J, Knol J: Chronic pelvic abscedation after completion proctectomy in an irradiated pelvis: another indication for ENDO-sponge treatment? Tech Coloproctol; 2009 Dec;13(4):311-4
MedlinePlus Health Information. consumer health - After Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chronic pelvic abscedation after completion proctectomy in an irradiated pelvis: another indication for ENDO-sponge treatment?
  • [MeSH-major] Abscess / surgery. Adenocarcinoma / surgery. Colectomy / adverse effects. Digestive System Surgical Procedures / adverse effects. Postoperative Complications / surgery. Rectal Neoplasms / surgery. Rectum / surgery. Surgical Sponges

  • MedlinePlus Health Information. consumer health - Abscess.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Plast Surg. 1997 Jun;38(6):563-76; discussion 577 [9188971.001]
  • [Cites] Br J Surg. 1989 Jun;76(6):605-6 [2758269.001]
  • [Cites] N Engl J Med. 2001 Aug 30;345(9):638-46 [11547717.001]
  • [Cites] Plast Reconstr Surg. 2006 Jun;117(7 Suppl):127S-142S [16799380.001]
  • [Cites] Dis Colon Rectum. 1999 Mar;42(3):403-18 [10223765.001]
  • [Cites] Int J Colorectal Dis. 2006 Oct;21(7):657-60 [16447032.001]
  • [Cites] Dis Colon Rectum. 2008 Apr;51(4):404-10 [18197452.001]
  • [Cites] Surg Endosc. 2008 Aug;22(8):1818-25 [18095024.001]
  • [Cites] Zentralbl Chir. 2006 Apr;131 Suppl 1:S115-9 [16575660.001]
  • [Cites] Ann Plast Surg. 1997 Jun;38(6):553-62 [9188970.001]
  • (PMID = 19603139.001).
  • [ISSN] 1128-045X
  • [Journal-full-title] Techniques in coloproctology
  • [ISO-abbreviation] Tech Coloproctol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


68. Pedersen ME, Rahr HB, Fenger C, Qvist N: Adenocarcinoma arising from the rectal stump eleven years after excision of an ileal J-pouch in a patient with ulcerative colitis: report of a case. Dis Colon Rectum; 2008 Jul;51(7):1146-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenocarcinoma arising from the rectal stump eleven years after excision of an ileal J-pouch in a patient with ulcerative colitis: report of a case.
  • We report a case of adenocarcinoma in the anal canal 11 years after removal of a failed ileal J-pouch.
  • The anus had been left in place at the pouch excision because of severe fibrosis in the pelvis.
  • [MeSH-major] Adenocarcinoma, Mucinous / etiology. Colitis, Ulcerative / surgery. Colonic Pouches / pathology. Rectal Neoplasms / etiology
  • [MeSH-minor] Anastomosis, Surgical. Biopsy. Diagnosis, Differential. Fatal Outcome. Follow-Up Studies. Humans. Ileostomy. Male. Middle Aged. Proctocolectomy, Restorative / methods. Time Factors. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Ulcerative Colitis.
  • MedlinePlus Health Information. consumer health - Ulcerative Colitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18437493.001).
  • [ISSN] 1530-0358
  • [Journal-full-title] Diseases of the colon and rectum
  • [ISO-abbreviation] Dis. Colon Rectum
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


69. Armah HB, Parwani AV, Perepletchikov AM: Synchronous primary carcinoid tumor and primary adenocarcinoma arising within mature cystic teratoma of horseshoe kidney: a unique case report and review of the literature. Diagn Pathol; 2009;4:17

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synchronous primary carcinoid tumor and primary adenocarcinoma arising within mature cystic teratoma of horseshoe kidney: a unique case report and review of the literature.
  • BACKGROUND: Malignant transformation of mature cystic teratoma is a rare complication.
  • While any of the constituent tissues of a teratoma has the potential to undergo malignant transformation, squamous cell carcinoma is the most commonly associated malignancy.
  • Renal teratoma rarely presents together with carcinoid tumor or adenocarcinoma.
  • To the best of our knowledge, there has never been a report of renal teratoma coexisting with both carcinoid tumor and adenocarcinoma.
  • METHODS: Here, we present a unique and first case of synchronous primary carcinoid tumor and moderately differentiated adenocarcinoma arising within mature cystic teratoma of horseshoe kidney in a 50-year-old female.
  • Further radiologic studies revealed horseshoe kidney and a large multi-septated cystic lesion immediately anterior to the right renal pelvis with central calcification and peripheral enhancement.
  • Microscopically, the tumor showed coexistent mature cystic teratoma, moderately differentiated adenocarcinoma and carcinoid tumor.
  • The adenocarcinoma component was strongly positive for cytokeratin 7 and pancytokeratin, weakly positive for synaptophysin and CD56, and negative for carbonic anhydrase IX, CD99, CDX2, chromogranin, cytokeratin 20 and smooth muscle actin.
  • She received no adjuvant therapy and is alive without evidence of disease six months after diagnosis and surgery.
  • CONCLUSION: This unique and first case herein presented with synchronous primary carcinoid tumor and primary adenocarcinoma arising within mature cystic teratoma of horseshoe kidney emphasizes the need for thorough sectioning and entire submission for histologic evaluation of mature cystic teratomas, in order to avoid missing multiple additional histogenetically distinct neoplasms.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BJU Int. 2009 Jun;103(11):1464-70 [19254281.001]
  • [Cites] Pathol Res Pract. 1999;195(12):865-6 [10631725.001]
  • [Cites] Can J Urol. 2009 Apr;16(2):4607-10 [19364438.001]
  • [Cites] J Urol. 2008 Nov;180(5):2193 [18804792.001]
  • [Cites] World J Surg Oncol. 2008;6:41 [18430248.001]
  • [Cites] Urol J. 2008 Winter;5(1):60-1 [18454431.001]
  • [Cites] Oncology (Williston Park). 2007 Nov;21(13):1593-6 [18179048.001]
  • [Cites] Pathol Int. 2008 Jan;58(1):51-4 [18067641.001]
  • [Cites] Chir Ital. 2007 Jul-Aug;59(4):559-63 [17966780.001]
  • [Cites] BJU Int. 2007 Nov;100(5):1030-5 [17784891.001]
  • [Cites] Hong Kong Med J. 2007 Oct;13(5):406-8 [17914151.001]
  • [Cites] Am J Surg Pathol. 2007 Oct;31(10):1539-44 [17895755.001]
  • [Cites] Diagn Cytopathol. 2007 Sep;35(9):597-600 [17703444.001]
  • [Cites] Int Urol Nephrol. 2007;39(2):373-6 [16835722.001]
  • [Cites] Diagn Pathol. 2007;2:15 [17509135.001]
  • [Cites] Diagn Cytopathol. 2007 May;35(5):306-10 [17427210.001]
  • [Cites] Arch Pathol Lab Med. 2006 Nov;130(11):1693-706 [17076534.001]
  • [Cites] J Urol. 2006 Dec;176(6 Pt 1):2359-66 [17085102.001]
  • [Cites] Urology. 2005 Sep;66(3):658 [16140109.001]
  • [Cites] Pathol Res Pract. 1999;195(1):25-30 [10048091.001]
  • [Cites] Urology. 1998 May;51(5A Suppl):121-4 [9610566.001]
  • [Cites] J Surg Oncol. 1998 Jun;68(2):113-9 [9624041.001]
  • [Cites] Scand J Urol Nephrol. 1997 Dec;31(6):575-8 [9458520.001]
  • [Cites] J Urol. 1997 Jun;157(6):2059-66 [9146580.001]
  • [Cites] Cancer. 1997 Feb 15;79(4):813-29 [9024720.001]
  • [Cites] Pathol Int. 1996 Nov;46(11):894-900 [8970200.001]
  • [Cites] Cancer Genet Cytogenet. 1995 Oct 15;84(2):95-8 [8536229.001]
  • [Cites] Gynecol Oncol. 1995 Dec;59(3):427-9 [8522269.001]
  • [Cites] Diagn Mol Pathol. 1995 Mar;4(1):48-53 [7735556.001]
  • [Cites] Hum Pathol. 1994 Feb;25(2):115-6 [8119711.001]
  • [Cites] Cancer. 1993 Nov 1;72(9):2660-6 [8402487.001]
  • [Cites] Gynecol Oncol. 1993 Jul;50(1):131-3 [8349156.001]
  • [Cites] Ultrastruct Pathol. 1991 Nov-Dec;15(6):655-61 [1724713.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 1988 Dec;29(4):329-38 [3229546.001]
  • [Cites] Urology. 1988 Dec;32(6):564-6 [3201667.001]
  • [Cites] Cancer. 1984 Nov 15;54(10):2305-8 [6386141.001]
  • [Cites] Cancer. 1976 Oct;38(4):1636-40 [991082.001]
  • [Cites] Experientia. 1976 Mar 15;32(3):377-8 [1253918.001]
  • [Cites] Med Times. 1966 Aug;94(8):895-6 [5938842.001]
  • [Cites] ScientificWorldJournal. 2004 Jun 3;4:378-80 [15311325.001]
  • [Cites] J Ultrasound Med. 2004 Mar;23(3):433-7 [15055793.001]
  • [Cites] Pathol Res Pract. 1999;195(12):864 [10631724.001]
  • [Cites] Pathol Int. 2003 May;53(5):317-22 [12713568.001]
  • [Cites] Histopathology. 2003 Feb;42(2):137-40 [12558745.001]
  • [Cites] In Vivo. 2002 May-Jun;16(3):197-9 [12182116.001]
  • [Cites] Arch Pathol Lab Med. 2002 Aug;126(8):979-81 [12171501.001]
  • [Cites] Mod Pathol. 2000 Sep;13(9):962-72 [11007036.001]
  • [Cites] Int J Urol. 2000 May;7(5):184-8 [10830826.001]
  • [Cites] Saudi J Kidney Dis Transpl. 2009 May;20(3):462-4 [19414952.001]
  • (PMID = 19523243.001).
  • [ISSN] 1746-1596
  • [Journal-full-title] Diagnostic pathology
  • [ISO-abbreviation] Diagn Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2704177
  •  go-up   go-down


70. Vaidyanathan S, Soni BM, Mansour P, Hughes PL, Singh G, Oo T: Effect of spinal cord injury upon prostate: adenocarcinoma of prostate in a spinal cord injury patient - a case report. Cases J; 2009;2:9374

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effect of spinal cord injury upon prostate: adenocarcinoma of prostate in a spinal cord injury patient - a case report.
  • Prostate biopsy revealed moderately differentiated primary adenocarcinoma of prostate; Gleason score was 3+3.
  • MRI of pelvis revealed no evidence of spread beyond prostatic capsule.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Urol. 2009 Aug;182(2):499-507; discussion 508 [19524966.001]
  • [Cites] Can Urol Assoc J. 2009 Jun;3(3 Suppl 2):S115-20 [19543430.001]
  • [Cites] Urology. 2009 May;73(5):935-9 [19328538.001]
  • [Cites] Scand J Urol Nephrol. 2007;41(2):120-3 [17454950.001]
  • [Cites] J Spinal Cord Med. 2001 Summer;24(2):92-4; discussion 95 [11587425.001]
  • [Cites] J Urol. 1997 Jan;157(1):195-8 [8976249.001]
  • [Cites] Arch Intern Med. 1995 Feb 27;155(4):389-92 [7531426.001]
  • [Cites] J Am Paraplegia Soc. 1994 Jul;17(3):148-9 [7964711.001]
  • [Cites] Spinal Cord. 2006 Jan;44(1):24-7 [16010271.001]
  • (PMID = 20062548.001).
  • [ISSN] 1757-1626
  • [Journal-full-title] Cases journal
  • [ISO-abbreviation] Cases J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2804017
  •  go-up   go-down


71. Kose F, Sakalli H, Sezer A, Mertsoylu H, Pourbagher A, Reyhan M, Ozyilkan O: Colon adenocarcinoma and solitary tibia metastasis: rare entity. J Gastrointest Cancer; 2008;39(1-4):146-8
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Colon adenocarcinoma and solitary tibia metastasis: rare entity.
  • CONCLUSION: Most common osseous metastatic sites are lumbal, sacral vertebrae, and pelvis region, probably because of colonic anatomical proximity to the paravertebral venous plexus.
  • [MeSH-major] Adenocarcinoma / pathology. Bone Neoplasms / secondary. Colonic Neoplasms / pathology. Tibia / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dis Colon Rectum. 1999 Dec;42(12):1592-7 [10613479.001]
  • [Cites] Br J Cancer. 1987 Jan;55(1):61-6 [3814476.001]
  • [Cites] Dis Colon Rectum. 1978 May-Jun;21(4):266-8 [657936.001]
  • [Cites] Pol Merkur Lekarski. 2004;17 Suppl 1:63-6 [15603351.001]
  • [Cites] Cancer Treat Rev. 2001 Jun;27(3):165-76 [11417967.001]
  • [Cites] Clin Colorectal Cancer. 2005 Jul;5(2):108-13 [16098251.001]
  • (PMID = 19241183.001).
  • [ISSN] 1941-6628
  • [Journal-full-title] Journal of gastrointestinal cancer
  • [ISO-abbreviation] J Gastrointest Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


72. Kalogiannidis I, Lambrechts S, Amant F, Neven P, VAN Limbergen E, Vergote I: Role of lymphadenectomy and pelvic radiotherapy in patients with clinical FIGO stage I endometrial adenocarcinoma: An analysis of 208 patients. Int J Gynecol Cancer; 2006 Sep-Oct;16(5):1885-93
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Role of lymphadenectomy and pelvic radiotherapy in patients with clinical FIGO stage I endometrial adenocarcinoma: An analysis of 208 patients.
  • High risk was defined as nonendometrioid, or endometrioid tumors grade 3 (G3), or G2 with any or G1 with deep (>1/2) myometrial infiltration.
  • The pelvic relapse rate was low as only one patient of group B recurred in the pelvis.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Adenocarcinoma / surgery. Endometrial Neoplasms / radiotherapy. Endometrial Neoplasms / surgery. Lymph Node Excision / adverse effects
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Middle Aged. Neoplasm Staging. Pelvis / surgery. Postoperative Complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17009987.001).
  • [ISSN] 1048-891X
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


73. Hong SH, Kim JC, Hwang TK: Laparoscopic partial cystectomy with en bloc resection of the urachus for urachal adenocarcinoma. Int J Urol; 2007 Oct;14(10):963-5
MedlinePlus Health Information. consumer health - Bladder Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic partial cystectomy with en bloc resection of the urachus for urachal adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / surgery. Cystectomy. Laparoscopy. Urachus / surgery. Urinary Bladder Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Humans. Lymph Node Excision. Male. Pelvis / surgery

  • Genetic Alliance. consumer health - Urachal adenocarcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17880303.001).
  • [ISSN] 0919-8172
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


74. Kirshtein B, Meirovitz M, Okon E, Piura B: Sister Mary Joseph's nodule as the first presenting sign of primary fallopian tube adenocarcinoma. J Minim Invasive Gynecol; 2006 May-Jun;13(3):234-6
Hazardous Substances Data Bank. CARBOPLATIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sister Mary Joseph's nodule as the first presenting sign of primary fallopian tube adenocarcinoma.
  • Final diagnosis was stage IIIB fallopian tube carcinoma.
  • It is concluded that in cases of Sister Mary Joseph's nodule, laparoscopy can be a useful tool in the search of the primary tumor in the abdomen and/or pelvis.
  • [MeSH-major] Abdominal Neoplasms / diagnosis. Adenocarcinoma / diagnosis. Fallopian Tube Neoplasms / diagnosis. Umbilicus
  • [MeSH-minor] Antineoplastic Agents / therapeutic use. Carboplatin / therapeutic use. Combined Modality Therapy. Female. Gynecologic Surgical Procedures. Humans. Laparoscopy. Middle Aged. Neoplasm Metastasis. Neoplasm Staging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16698532.001).
  • [ISSN] 1553-4650
  • [Journal-full-title] Journal of minimally invasive gynecology
  • [ISO-abbreviation] J Minim Invasive Gynecol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; BG3F62OND5 / Carboplatin
  •  go-up   go-down


75. Chi DS, Barakat RR, Palayekar MJ, Levine DA, Sonoda Y, Alektiar K, Brown CL, Abu-Rustum NR: The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer; 2008 Mar-Apr;18(2):269-73
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.
  • We also included only patients who had adequate staging, which was defined as a total hysterectomy with removal of at least eight pelvic lymph nodes.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Lymphatic Metastasis. Middle Aged. Neoplasm Staging. Pelvis

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18334008.001).
  • [ISSN] 1525-1438
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


76. Kannan V, Sathiyanarayanan VK, Sagde S, Anand V, Almel S, Kapadia A, Srinivas V: Three dimensional conformal radiation therapy in prostate adenocarcinoma: survival and rectal toxicity. J Cancer Res Ther; 2005 Jan-Mar;1(1):34-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Three dimensional conformal radiation therapy in prostate adenocarcinoma: survival and rectal toxicity.
  • Treatment method consisted of pelvis and leg immobilization, planning CT scan, marking of planning target volume and organs at risk and 3D beam plan using multileaf collimated beam shaping through beam's eye view display.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Prostatic Neoplasms / radiotherapy. Rectum / radiation effects

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17998623.001).
  • [ISSN] 1998-4138
  • [Journal-full-title] Journal of cancer research and therapeutics
  • [ISO-abbreviation] J Cancer Res Ther
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  •  go-up   go-down


77. Shinohara N, Harabayashi T, Suzuki S, Nakamura M, Itoh T, Nonomura K: Advanced renal pelvic carcinoma associated with dermatomyositis. Int J Urol; 2005 Oct;12(10):906-8
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Computed tomography showed a solid mass in the pelvis of the left kidney and lymphadenopathy in the retroperitoneum.
  • The pathological specimen showed moderately differentiated adenocarcinoma, stage pT3N2.
  • [MeSH-major] Adenocarcinoma / etiology. Dermatomyositis / complications. Kidney Neoplasms / etiology
  • [MeSH-minor] Adult. Fatal Outcome. Follow-Up Studies. Humans. Kidney Pelvis / pathology. Kidney Pelvis / radiography. Male. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Dermatomyositis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16323985.001).
  • [ISSN] 0919-8172
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


78. Mimura A, Sakuma T, Furuta M, Tanigawa N, Takamizu R, Kawano K: Sarcomatoid collecting duct carcinoma of kidney diagnosed with urine and renal pelvic lavage cytology. Diagn Cytopathol; 2010 Aug;38(8):603-6
MedlinePlus Health Information. consumer health - Urine and Urination.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A case of sarcomatoid collecting duct carcinoma (CDC) of kidney is presented, in which the diagnosis was made cytologically with voided urine and renal pelvis lavage.
  • Cytology of hemorrhagic voided urine revealed highly atypical adenocarcinoma cells with reminiscent ductal structure, which suggested CDC as the most likely diagnosis.
  • Computed tomography and magnetic resonance imaging demonstrated a left renal tumor, and selective lavage of left renal pelvis yielded spindle-shaped, highly atypical cells that indicated sarcomatoid carcinoma.
  • The diagnosis of renal cancer with urine cytology is challenging because of small number of tumor cells in the urine, which are often associated with degeneration.
  • [MeSH-major] Cytological Techniques / methods. Kidney Neoplasms / diagnosis. Kidney Pelvis / pathology. Kidney Tubules, Collecting / pathology. Sarcoma / diagnosis. Therapeutic Irrigation. Urine / cytology


79. Funahashi Y, Kamihira O, Kasugai S, Kimura K, Fukatsu A, Matsuura O: [Triple cancer in the urinary system: a case report]. Hinyokika Kiyo; 2007 Nov;53(11):813-5
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Intravenous pyelography also showed deformity of the right kidney and shadow defects in the left renal pelvis.
  • Abdominal computed tomography revealed an 8 cm tumor invading the renal vein in the right kidney, and a 3 cm tumor in the left renal pelvis.
  • [MeSH-major] Adenocarcinoma / diagnosis. Carcinoma, Renal Cell / diagnosis. Kidney Neoplasms / diagnosis. Kidney Pelvis. Neoplasms, Multiple Primary. Prostatic Neoplasms / diagnosis. Urinary Bladder Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18051808.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 8
  •  go-up   go-down


80. Tao Y, Lefkopoulos D, Ibrahima D, Bridier A, Polizzi Mdel P, Wibault P, De Crevoisier R, Arriagada R, Bourhis J: Comparison of dose contribution to normal pelvic tissues among conventional, conformal and intensity-modulated radiotherapy techniques in prostate cancer. Acta Oncol; 2008;47(3):442-50
MedlinePlus Health Information. consumer health - Prostate Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, IMRT significantly reduced the irradiated volume of the rectum in the dose range of 5 to 40 Gy, also significantly reduced the irradiated volume of bladder and femoral heads, and obtained a similar or improved isodose distribution in the PTvs. In addition, the use of IMRT slightly increased the relative dose delivered to the body volume outside the pelvis, as estimated by the use of specific software.
  • A long-term follow-up will be needed to evaluate potential late treatment complications related to the use of IMRT and the low or moderate irradiation dose level obtained in the pelvis and in the whole body.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Pelvis / radiation effects. Prostatic Neoplasms / radiotherapy. Radiotherapy Dosage. Radiotherapy, Conformal. Radiotherapy, Intensity-Modulated

  • Genetic Alliance. consumer health - Prostate cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17906985.001).
  • [ISSN] 1651-226X
  • [Journal-full-title] Acta oncologica (Stockholm, Sweden)
  • [ISO-abbreviation] Acta Oncol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Norway
  •  go-up   go-down


81. Taranto AJ, Lourie R, Lau WF: Ovarian vascular pedicle sign in ovarian metastasis arising from gall bladder carcinoma. Australas Radiol; 2006 Oct;50(5):504-6
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A case of a large mass in the pelvis confirmed to be a rare ovarian metastasis arising from a primary adenocarcinoma of the gall bladder is presented.
  • [MeSH-major] Adenocarcinoma / pathology. Gallbladder Neoplasms / pathology. Ovarian Neoplasms / diagnosis. Ovarian Neoplasms / secondary. Ovary / radiography. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Contrast Media / administration & dosage. Diagnosis, Differential. Female. Fluorodeoxyglucose F18. Humans. Middle Aged. Positron-Emission Tomography / methods. Radiographic Image Enhancement / methods. Rare Diseases

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Gallbladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16981953.001).
  • [ISSN] 0004-8461
  • [Journal-full-title] Australasian radiology
  • [ISO-abbreviation] Australas Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Contrast Media; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


82. Tanyi JA, He T, Summers PA, Mburu RG, Kato CM, Rhodes SM, Hung AY, Fuss M: Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion. Int J Radiat Oncol Biol Phys; 2010 Dec 1;78(5):1579-85
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Transponder positioning was verified by volumetric imaging with cone-beam computed tomography of the pelvis.
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / radiography. Adenocarcinoma / radiotherapy. Dose Fractionation. Electromagnetic Fields. Humans. Male. Patient Positioning. Pelvis / radiography. Phantoms, Imaging. Quality Assurance, Health Care. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20472357.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


83. Dallinger B, Würnschimmel E: [Appearance of carcinosarcoma after radiotherapy for local recurrence after radical prostatectomy. Case report and review of the literature]. Urologe A; 2010 Jun;49(6):750-4
MedlinePlus Health Information. consumer health - Prostate Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the case of rapid tumor progression, especially after radiation therapy to the pelvis or after hormone deprivation therapy because of prostate cancer, this tumor entity should be considered, and immediate histological confirmation is required.
  • We report about the first case of a carcinosarcoma after salvage radiation therapy for local recurrence of adenocarcinoma of the prostate years after radical prostatectomy.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Adenocarcinoma / surgery. Carcinosarcoma / diagnosis. Neoplasm Recurrence, Local / radiotherapy. Neoplasm Recurrence, Local / surgery. Neoplasms, Radiation-Induced / diagnosis. Neoplasms, Second Primary / diagnosis. Prostatectomy. Prostatic Neoplasms / diagnosis. Prostatic Neoplasms / radiotherapy. Prostatic Neoplasms / surgery. Salvage Therapy / methods
  • [MeSH-minor] Aged. Combined Modality Therapy. Cystectomy. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Invasiveness. Penis / pathology. Penis / surgery. Pubic Bone / pathology. Pubic Bone / surgery. Radiotherapy, Adjuvant / adverse effects. Urinary Bladder / pathology. Urinary Bladder / radiation effects

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Urol. 1985 Jan;133(1):58-60 [3917295.001]
  • [Cites] Hinyokika Kiyo. 2007 Nov;53(11):817-9 [18051809.001]
  • [Cites] Am J Surg Pathol. 2006 Oct;30(10):1316-21 [17001164.001]
  • [Cites] Prostate Cancer Prostatic Dis. 2006;9(2):195-7 [16568146.001]
  • [Cites] Urologe A. 2008 Nov;47(11):1441-6 [18806991.001]
  • [Cites] Am J Surg Pathol. 1993 Apr;17(4):342-9 [8494104.001]
  • [Cites] Cancer. 1995 Sep 15;76(6):1035-42 [8625205.001]
  • [Cites] J Urol. 2003 Jan;169(1):157-63 [12478126.001]
  • [Cites] Tech Urol. 2001 Dec;7(4):294-5 [11763492.001]
  • [Cites] Urology. 2009 Sep;74(3):540-1 [19589566.001]
  • [Cites] Ann Diagn Pathol. 2008 Apr;12(2):142-5 [18325477.001]
  • [Cites] Urol Int. 1997;59(1):50-2 [9313326.001]
  • [Cites] J Urol. 2006 Nov;176(5):2025-31; discussion 2031-2 [17070244.001]
  • [Cites] Int J Urol. 2003 Feb;10(2):108-13 [12588610.001]
  • [Cites] Eur Urol. 2006 Dec;50(6):1357-9 [16814927.001]
  • [Cites] Urologe A. 2006 Apr;45(4):474-81 [16465521.001]
  • [Cites] J Urol. 2006 Nov;176(5):2033-8; discussion 2038-9 [17070247.001]
  • [Cites] Ann Urol (Paris). 1999;33(4):263-7 [10510708.001]
  • [Cites] BJU Int. 2008 Nov;102(10):1369-74 [18793296.001]
  • [Cites] Onkologie. 2002 Dec;25(6):558-61 [12566902.001]
  • [Cites] J Urol. 2008 Jan;179(1):91-5; discussion 95 [17997457.001]
  • [Cites] JSLS. 2007 Jan-Mar;11(1):109-12 [17651569.001]
  • (PMID = 20237907.001).
  • [ISSN] 1433-0563
  • [Journal-full-title] Der Urologe. Ausg. A
  • [ISO-abbreviation] Urologe A
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


84. Behtash N, Karimi Zarchi M, Deldar M: Preoperative prognostic factors and effects of adjuvant therapy on outcomes of early stage cervical cancer in Iran. Asian Pac J Cancer Prev; 2009 Oct-Dec;10(4):613-8
International Agency for Research on Cancer - Screening Group. diagnostics - A practical manual on visual screening for cervical neoplasia .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The depth of cervical stromal invasion, clinical stage, histology of pure adenocarcinoma and lymph node (LN) status were important histopathological prognostic factors of cervical carcinoma.
  • [MeSH-major] Adenocarcinoma / secondary. Adenocarcinoma / therapy. Uterine Cervical Neoplasms / pathology. Uterine Cervical Neoplasms / therapy
  • [MeSH-minor] Adult. Chemotherapy, Adjuvant. Combined Modality Therapy. Female. Follow-Up Studies. Humans. Hysterectomy. Lymph Node Excision. Lymphatic Metastasis. Middle Aged. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / therapy. Neoplasm Staging. Pelvis. Preoperative Care. Prognosis. Radiotherapy, Adjuvant. Survival Rate. Young Adult


85. Burbos N, Giarenis I, Ostrowski J, Lonsdale R, Nieto JJ: Synchronous diagnosis of multiple tumours in a postmenopausal woman. Arch Gynecol Obstet; 2009 Oct;280(4):627-30

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synchronous diagnosis of multiple tumours in a postmenopausal woman.
  • A CT scan showed a malignant-appearing right ovarian mass with a peritoneal nodule, small amount of free fluid in the pelvis and evidence of a colonic intussusception.
  • Histopathology showed a Grade 3 endometrial adenocarcinoma.
  • Both ovaries were completely replaced by partially necrotic poorly differentiated endometrioid adenocarcinoma.
  • Small deposits of metastatic adenocarcinoma were seen within the omentum.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenoma / diagnosis. Colonic Neoplasms / diagnosis. Genital Neoplasms, Female / diagnosis. Liposarcoma / diagnosis. Neoplasms, Multiple Primary / diagnosis. Retroperitoneal Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19198863.001).
  • [ISSN] 1432-0711
  • [Journal-full-title] Archives of gynecology and obstetrics
  • [ISO-abbreviation] Arch. Gynecol. Obstet.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


86. Trna J, Husová L, Oliverius M, Dastych M Jr, Senkyrík M, Príbramská V: [The case of familial adenomatous polyposis and a proposal for the system of dispensarisation]. Vnitr Lek; 2009 Jun;55(6):587-92
Genetic Alliance. consumer health - Familial Polyposis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The adenocarcinoma had been treated using all available oncology therapeutic modalities.
  • When the conservative methods, including enteral and, subsequently, home total parenteral nutrition, were unsuccessful, the patient underwent successful surgery with resection of the affected intestinal loops, part of the bladder, evacuation of an abscess in the small pelvis and terminal jejunostomy.
  • [MeSH-minor] Adenocarcinoma / surgery. Colonic Neoplasms / surgery. Digestive System Surgical Procedures / adverse effects. Female. Humans. Middle Aged. Short Bowel Syndrome / etiology. Short Bowel Syndrome / therapy

  • Genetic Alliance. consumer health - Familial Adenomatous Polyposis (FAP).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19662891.001).
  • [ISSN] 0042-773X
  • [Journal-full-title] Vnitr̆ní lékar̆ství
  • [ISO-abbreviation] Vnitr Lek
  • [Language] cze
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Czech Republic
  •  go-up   go-down


87. Asao T, Sakurai H, Harashima K, Yamaguchi S, Tsutsumi S, Nonaka T, Shioya M, Nakano T, Kuwano H: The synchronization of chemotherapy to circadian rhythms and irradiation in pre-operative chemoradiation therapy with hyperthermia for local advanced rectal cancer. Int J Hyperthermia; 2006 Aug;22(5):399-406
Hazardous Substances Data Bank. LEUCOVORIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: The therapeutic and adverse effects of pre-operative chrono-chemoradiation with local hyperthermia for patients with rectal adenocarcinoma were evaluated.
  • MATERIALS AND METHODS: Pre-operative radiation therapy of a total dose of 40 Gy (n = 10) or 50 Gy (n = 19) on the whole pelvis and hyperthermia once a week during the radiation therapy for 1 h were performed for patients with T2-T4 rectal adenocarcinoma.
  • CONCLUSIONS: These results yielded a high response rate with minimal toxicities for advanced low-rectal adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / therapy. Chronotherapy / methods. Rectal Neoplasms / therapy

  • Genetic Alliance. consumer health - Rectal Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16891242.001).
  • [ISSN] 0265-6736
  • [Journal-full-title] International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
  • [ISO-abbreviation] Int J Hyperthermia
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 12001-76-2 / Vitamin B Complex; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil
  •  go-up   go-down


88. Park JY, Lim MC, Lim SY, Bae JM, Yoo CW, Seo SS, Kang S, Park SY: Port-site and liver metastases after laparoscopic pelvic and para-aortic lymph node dissection for surgical staging of locally advanced cervical cancer. Int J Gynecol Cancer; 2008 Jan-Feb;18(1):176-80
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Port-site and liver metastases after laparoscopic pelvic and para-aortic lymph node dissection for surgical staging of locally advanced cervical cancer.
  • Recently, we experienced a case of port-site and liver metastases after 75 cases of laparoscopic transperitoneal pelvic lymph node dissection (PLND) and para-aortic lymph node dissection (PALND) for surgical staging of locally advanced cervical cancer.
  • A 45-year-old-woman with stage IIB cervical adenocarcinoma underwent laparoscopic PLND and PALND for surgical staging.
  • One month after the completion of therapy, both lateral and umbilical port-site and liver metastases were detected.
  • We conclude that although cases of port-site metastasis have mostly occurred after extensive disease, the possibility of such complication should be kept in mind at laparoscopy of early cancer and laparoscopy which does not manipulate primary tumor.
  • [MeSH-major] Adenocarcinoma / secondary. Laparoscopy. Liver Neoplasms / secondary. Lymph Nodes / surgery. Pelvis / surgery. Uterine Cervical Neoplasms / pathology
  • [MeSH-minor] Female. Humans. Lymph Node Excision. Middle Aged. Neoplasm Staging

  • Genetic Alliance. consumer health - Liver cancer.
  • Genetic Alliance. consumer health - Cervical cancer.
  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17506848.001).
  • [ISSN] 1525-1438
  • [Journal-full-title] International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
  • [ISO-abbreviation] Int. J. Gynecol. Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


89. Tabrizi AD, Kalloger SE, Köbel M, Cipollone J, Roskelley CD, Mehl E, Gilks CB: Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases. Int J Gynecol Pathol; 2010 Mar;29(2):99-107
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Primary ovarian mucinous carcinomas of the intestinal type are uncommon and earlier reports have included cases diagnosed according to older, less stringent, criteria (which would now be considered borderline tumors) and variable numbers of cases of metastatic adenocarcinoma.
  • Our findings support current diagnostic criteria for primary ovarian mucinous carcinoma, that is, the presence of expansile invasion, in the absence of destructive invasion, warrants a diagnosis of carcinoma.
  • A large majority of mucinous carcinomas show only an expansile pattern of invasion and are confined to the pelvis at diagnosis.
  • [MeSH-major] Adenocarcinoma, Mucinous / metabolism. Adenocarcinoma, Mucinous / pathology. Ovarian Neoplasms / metabolism. Ovarian Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20173494.001).
  • [ISSN] 1538-7151
  • [Journal-full-title] International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • [ISO-abbreviation] Int. J. Gynecol. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


90. Tagami K, Tanda S, Tokumura H, Yamaguchi M: [A case of triple malignant tumors consisting of esophagus, stomach and malignant lymphoma with a histopathological feature of collision between gastric cancer and malignant lymphoma--a case report]. Gan To Kagaku Ryoho; 2010 Dec;37(13):2891-5
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of triple malignant tumors consisting of esophagus, stomach and malignant lymphoma with a histopathological feature of collision between gastric cancer and malignant lymphoma--a case report].
  • We report a rare case of a collision between a gastric cancer and a malignant lymphoma with a wide systemic metastasis, combined with esophagus cancer, stomach cancer and malignant lymphoma.
  • Magnetic resonance imaging (MRI) revealed that both testes were swollen with unequal contrast and there were numerous tumors in the retroperitoneal space and pelvis.
  • He was diagnosed with malignant diffuse large B cell lymphoma by immunostaining from the extirpated right testis.
  • During this chemotherapy, he felt epigastralgia; esophagus cancer (squamous cell carcinoma) and stomach cancer (highly-differentiated adenocarcinoma) were found by upper endoscopy.
  • However, the gastrointestinal cancer was inoperable, since the malignant lymphoma was progressive.
  • His general status had been exacerbated, and he died about one year after he was diagnosed with malignant lymphoma.
  • Pathological examination revealed that the adenocarcinoma had partly collided with the malignant lymphoma.
  • [MeSH-major] Adenocarcinoma / pathology. Carcinoma, Squamous Cell / pathology. Esophageal Neoplasms / pathology. Lymphoma, Large B-Cell, Diffuse / pathology. Neoplasms, Multiple Primary / pathology. Stomach Neoplasms / pathology

  • Genetic Alliance. consumer health - Gastric Lymphoma.
  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21160264.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


91. Yamada T, Mori H, Kanemura M, Ohmichi M, Shibayama Y: Endometrial carcinoma with choriocarcinomatous differentiation: a case report and review of the literature. Gynecol Oncol; 2009 May;113(2):291-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Choriocarcinomas unrelated to pregnancy, teratomas, or germ cell tumors have been found in the stomach, lungs, colon, esophagus, bladder, breast, renal pelvis and other sites.
  • She received surgery and chemotherapy for endometrial adenocarcinoma.
  • CONCLUSION: Treatment and follow-up must be performed not only for the adenocarcinoma element but also for the choriocarcinoma element in patients presenting with endometrial carcinoma with choriocarcinomatous differentiation.
  • [MeSH-minor] Adenocarcinoma / drug therapy. Adenocarcinoma / pathology. Adenocarcinoma / surgery. Female. Humans. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19232701.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


92. Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI, Zaino RJ: A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys; 2006 May 1;65(1):169-76
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • With RT, 8.8% of patients (3 of 34) with adenosquamous or adenocarcinoma tumors recurred vs. 44.0% (11 of 25) in OBS.
  • Fewer recurrences were seen with RT in patients with adenocarcinoma or adenosquamous histologies relative to others (HR for RT by histology interaction = 0.23, 90% CI = 0.07 to 0.74, p = 0.019).
  • RT appears to be particularly beneficial for patients with adenocarcinoma or adenosquamous histologies.
  • [MeSH-major] Neoplasm Recurrence, Local. Uterine Cervical Neoplasms / radiotherapy
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / radiotherapy. Adenocarcinoma / surgery. Carcinoma, Adenosquamous / pathology. Carcinoma, Adenosquamous / radiotherapy. Carcinoma, Adenosquamous / surgery. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / radiotherapy. Carcinoma, Squamous Cell / surgery. Female. Humans. Hysterectomy. Lymph Node Excision. Pelvis. Radiotherapy Dosage. Survival Analysis

  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16427212.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA 27469; United States / NCI NIH HHS / CA / CA 37517
  • [Publication-type] Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  •  go-up   go-down


93. Park NY, Seong WJ, Chong GO, Hong DG, Cho YL, Park IS, Lee YS: The effect of nonperitonization and laparoscopic lymphadenectomy for minimizing the incidence of lymphocyst formation after radical hysterectomy for cervical cancer. Int J Gynecol Cancer; 2010 Apr;20(3):443-8
International Agency for Research on Cancer - Screening Group. diagnostics - Planning and Implementing Cervical Cancer Prevention and Control Programs: A Manual for Managers .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Lymphocyst formation was associated with an increase in the total amount of lymphatic drainage in group A (P = 0.090) and group B (P = 0.041) and a pathologic type of adenocarcinoma in group B (P = 0.016).
  • [MeSH-major] Adenocarcinoma / surgery. Carcinoma, Squamous Cell / surgery. Hysterectomy. Lymph Node Excision. Lymphocele / prevention & control. Peritoneum / surgery. Uterine Cervical Neoplasms / surgery
  • [MeSH-minor] Electrocoagulation. Female. Follow-Up Studies. Humans. Incidence. Middle Aged. Neoplasm Staging. Pelvis / pathology. Pelvis / surgery. Postoperative Complications. Prognosis. Retrospective Studies


94. Guillem JG, Chessin DB, Jeong SY, Kim W, Fogarty JM: Contemporary applications of transanal endoscopic microsurgery: technical innovations and limitations. Clin Colorectal Cancer; 2005 Nov;5(4):268-73
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: Transanal endoscopic microsurgery (TEM) is a minimally invasive procedure used to transanally excise select benign and malignant tumors of the rectum.
  • RESULTS: Transanal endoscopic microsurgery was performed for rectal adenocarcinoma (n = 17; 53%), adenoma (n = 12; 38%), and carcinoid tumors (n = 3; 9%).
  • Reasons for inability to complete TEM included narrow rectal lumen or contour of bony pelvis prohibiting passage of the operating proctoscope into the upper rectum and inability to maintain the proctoscope in the rectal lumen with carbon dioxide insufflation because of the distal location of the tumor.
  • [MeSH-major] Adenocarcinoma / surgery. Adenoma / surgery. Carcinoid Tumor / surgery. Colonoscopy / methods. Rectal Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Anal Canal. Female. Humans. Male. Microsurgery. Middle Aged. Neoplasm Staging. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Carcinoid Tumors.
  • MedlinePlus Health Information. consumer health - Colonoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16356304.001).
  • [ISSN] 1533-0028
  • [Journal-full-title] Clinical colorectal cancer
  • [ISO-abbreviation] Clin Colorectal Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


95. Abelevich AI, Komarov DV, larin AA, Dezortsev IL, Patsenker EN: [Aspects of low anterior rectum resection]. Khirurgiia (Mosk); 2008;(6):63-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Results analysis of 162 low anterior rectum resections, carried out in the hospital during 1999-2006 years on account of upper and medial rectal ampulla adenocarcinoma is presented in the article.
  • Measures for prediction and prophylaxis of anal incontinence after rectum resection and also the new method of small pelvis cavity intraoperative drainage were offered.
  • [MeSH-major] Adenocarcinoma / pathology. Adenocarcinoma / surgery. Rectal Neoplasms / pathology. Rectal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18577949.001).
  • [ISSN] 0023-1207
  • [Journal-full-title] Khirurgiia
  • [ISO-abbreviation] Khirurgiia (Mosk)
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


96. Fanning J, Hossler C: Laparoscopic conversion rate for uterine cancer surgical staging. Obstet Gynecol; 2010 Dec;116(6):1354-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To estimate the conversion rate of attempted laparoscopic staging for primary endometrial adenocarcinoma.
  • METHODS: Two hundred thirty-five consecutive patients with primary endometrial adenocarcinoma underwent attempted laparoscopic staging regardless of age, body mass index (BMI, calculated as weight (kg)/[height (m)]²), uterine size, and prior surgery.
  • CONCLUSION: Of 235 consecutive cases of attempted laparoscopic staging for primary endometrial adenocarcinoma, conversion to laparotomy or vaginal hysterectomy occurred in 3% of the total patients and 7% in patients with a BMI of 40 or higher.
  • [MeSH-major] Adenocarcinoma / surgery. Endometrial Neoplasms / surgery. Hysterectomy, Vaginal. Laparoscopy. Laparotomy
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Blood Loss, Surgical. Body Mass Index. Female. Humans. Lymph Node Excision. Middle Aged. Neoplasm Staging. Pelvis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21099602.001).
  • [ISSN] 1873-233X
  • [Journal-full-title] Obstetrics and gynecology
  • [ISO-abbreviation] Obstet Gynecol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


97. Martínez-Román S, Frumovitz M, Deavers MT, Ramirez PT: Metastatic carcinoma of the gallbladder mimicking an advanced cervical carcinoma. Gynecol Oncol; 2005 Jun;97(3):942-5
International Agency for Research on Cancer - Screening Group. diagnostics - A practical manual on visual screening for cervical neoplasia .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Metastasis to the uterine cervix from a non-gynecologic neoplasm is extremely rare.
  • A computed tomography (CT) scan of the pelvis showed left-sided hydronephrosis and hydroureter with distal ureteral obstruction.
  • A Pap smear revealed adenocarcinoma, and a biopsy of the endocervical canal was consistent with poorly differentiated adenocarcinoma.
  • The patient underwent a CT-guided biopsy of one of the lung lesions and the pathologic findings were consistent with metastatic adenocarcinoma.
  • The patient was diagnosed with stage IVB primary gallbladder adenocarcinoma and was treated with capecitabine, but her condition deteriorated rapidly and she died 5 months later.
  • CONCLUSION: In patients with an atypical presentation for cervical adenocarcinoma, it is important to consider a metastatic tumor in the differential diagnosis and to perform a thorough work-up for metastatic disease before initiating therapy.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / secondary. Gallbladder Neoplasms / diagnosis. Gallbladder Neoplasms / pathology. Uterine Cervical Neoplasms / diagnosis. Uterine Cervical Neoplasms / secondary
  • [MeSH-minor] Aged. Diagnosis, Differential. Female. Humans


98. Frumovitz M, Gayed IW, Jhingran A, Euscher ED, Coleman RL, Ramirez PT, Levenback CF: Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol; 2008 Mar;108(3):478-81
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Among these 11 patients, 5 (45%) had sentinel nodes identified in the groin only, 4 (36%) had sentinel nodes identified in the pelvis only, and 2 (18%) had sentinel nodes identified in both the groin and the pelvis.
  • [MeSH-major] Lymph Nodes / pathology. Pelvis / pathology. Sentinel Lymph Node Biopsy. Vaginal Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / pathology. Adult. Aged. Aged, 80 and over. Carcinoma, Squamous Cell / pathology. Female. Humans. Lymphatic Metastasis. Melanoma / pathology. Middle Aged. Predictive Value of Tests. Radionuclide Imaging / methods. Retrospective Studies. Sensitivity and Specificity. Technetium Tc 99m Sulfur Colloid

  • Genetic Alliance. consumer health - Vaginal cancer.
  • MedlinePlus Health Information. consumer health - Vaginal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18190952.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 556Q0P6PB1 / Technetium Tc 99m Sulfur Colloid
  •  go-up   go-down


99. Marchesi V, Graff P, Noel A, Beckendorf V, Peiffert D: [Optimisation and evaluation of the foetal dose during a radiotherapy of the right parotid]. Cancer Radiother; 2008 Sep;12(5):380-4
MedlinePlus Health Information. consumer health - Tumors and Pregnancy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Optimisation et évaluation de la dose foetale pendant une radiothérapie de la parotide droite.
  • Purpose was to optimize and to estimate the dose delivered to the foetus during a postoperative irradiation of a 5-month twin pregnant woman presenting with adenocarcinoma of the right parotid.
  • A series of measurements allowed to estimate the delivered dose in the abdomen by the means of an ion chamber inserted in a water phantom placed side by side of an anthropomorphic Alderson Rando phantom simulating the body of the patient from the head to the pelvis.
  • An appropriate optimisation of the number and orientation of beams were performed in order to minimize the peripheral dose, which is mostly dependent of the total number of monitor unit per fraction: cervical nodes and tumour site included in the same fields, limitation of the irradiated volume, 6 MV X-ray beams rather than Cobalt beams.
  • [MeSH-major] Adenocarcinoma / radiotherapy. Parotid Neoplasms / radiotherapy. Pregnancy Complications, Neoplastic / radiotherapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18486513.001).
  • [ISSN] 1278-3218
  • [Journal-full-title] Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
  • [ISO-abbreviation] Cancer Radiother
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


100. Busby JE, Brown GA, Tamboli P, Kamat AM, Dinney CP, Grossman HB, Matin SF: Upper urinary tract tumors with nontransitional histology: a single-center experience. Urology; 2006 Mar;67(3):518-23
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Sixteen patients (1.9% of our database of patients with upper urinary tract tumors) were identified; 12 had squamous cell carcinoma, 2 had adenocarcinoma, 1 had sarcomatoid carcinoma, and 1 had small cell carcinoma.
  • The tumors were located in the renal pelvis in 10 and the ureter in 6.
  • CONCLUSIONS: Primary nonurothelial carcinomas of the renal pelvis and ureter are rare.
  • Our analysis suggests a poor prognosis for most patients with these pathologic types, probably resulting from the advanced stage at diagnosis and poor responses to systemic therapy.
  • [MeSH-major] Carcinoma / pathology. Kidney Neoplasms / pathology. Kidney Pelvis. Ureteral Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16527570.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA79449; United States / NCI NIH HHS / CA / CA91846
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down






Advertisement